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Introduction: Thesis Overview 
Breast cancer is the most common cancer in the UK and responsible for the second 
highest number of cancer deaths in women (Cancer Research UK, 2013). Prognostic 
developments are making it increasingly possible to identify those at increased risk of 
the disease and advances in cancer risk reduction strategies aim to reduce women’s 
risk of developing breast cancer. However, the risk-reducing strategies available to 
women have different risk-reducing capabilities and some can have negative side 
effects. Women at increased risk of breast cancer are faced with a series of complex 
decisions including whether or not to act to reduce their level of risk, along with the 
risk and benefits of different risk-reducing options.  
Health decision theories afford a central role for risk perception in the uptake of 
health protection behaviour. To date, there has been mixed evidence for the role of 
risk perception in the uptake of breast cancer risk-reducing behaviour. Within the 
quantitative research paradigm, risk perception is often measured as a quantitative 
estimate, driven by an assumption that women perceive risk in numerical and 
dimensional terms. This research tells us very little about the forms in which women 
represent risk and the influence of these risk representations on choices; possibly 
explaining why studies often show weak relationships between risk perceptions and 
behaviour. In an effort to further our understanding of women’s choices in this area, 
the literature review aimed to synthesise qualitative literature that explored how 
women at increased risk of breast cancer perceived risk and the role of risk 
perceptions in decisions regarding risk-reducing strategies.  
Women deemed to be at a significantly increased risk of breast cancer can choose to 
undertake risk-reducing mastectomy (RRM), the surgical removal of breast tissue for 
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risk-reducing purposes. This procedure is controversial because of the potential for 
physical and psychological harm and the mixed evidence regarding the survival 
benefits. Findings from a case series of women undertaking RRM (Beesley, 
Holcombe, Brown, & Salmon, 2013) suggest that women were driven to opt for the 
procedure because of a sense of vulnerability to cancer and desire for cosmesis. These 
findings call into question the role that risk perception plays in this decision-making 
process. Conclusions however are limited by the case series design and sparse 
reflection on the relevance of the findings to theoretical understanding. The empirical 
study aimed to explore, using in-depth interviews, how women make decisions 
regarding RRM and to identify implications of the findings for the role of decision 
support for women considering RRM and for psychological theory. 
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Abstract 
Options for breast cancer risk reduction are available, but it is unclear how women 
balance risks of cancer, cancer risk reduction and the risks of side effects. The aim of 
the review was to understand how women at increased risk of breast cancer 
understand risk and how their ways of understanding it influence decision-making 
regarding risk-reducing options. SCOPUS, Web of Knowledge, PsychINFO and 
Medline electronic databases were searched for published empirical papers. English 
language, qualitative studies that explored risk perception in adult women at increased 
risk of breast cancer were included. The 14 included studies were assessed for quality 
using the CASP assessment tool and presented in a narrative synthesis. Women 
largely did not see risk in dimensional terms, but were more likely to report 
categorical representation of risk. Most commonly, risk was perceived in emotional 
terms and was sometimes defined by family experience. Women reported that 
emotional representations of risk were most strongly associated with decision-making. 
These findings question the assumptions of utility models of decision-making that 
emphasise considered and logical understandings of risk. Implications of this are that 
the conceptualisation of what constitutes ‘good’ decision-making about risk will need 
to be questioned in the light of how women actually do make decisions.    
 
 
 
Keywords: Breast cancer, risk reduction, risk perception, qualitative, systematic 
review 
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How do Women at Increased Risk of Breast Cancer Perceive and Act on Risk? A 
Systematic Review 
Breast cancer is the most commonly diagnosed cancer in the United Kingdom (Cancer 
Research UK [CRUK], 2013) and causes the second highest number of cancer deaths 
in women in the UK (Office of National Statistics [ONS], 2012). Diagnosis, treatment 
and survivorship of the disease can bring a multitude of negative physical, social and 
psychological consequences (Amir & Ramati, 2002; Bower et al., 2000; Bradley, 
Bednarek, & Neumark, 2002). Recent advances in prognostic instruments have made 
it possible to identify women who are at increased risk of breast cancer. 
Quantification of this risk allows women to make choices that will reduce their level 
of risk.  
Different options are available to reduce risk of breast cancer but they do so to 
different degrees and most have side effects. Thus, women considering risk-reducing 
procedures face complex decisions. These involve balancing their risk of developing 
breast cancer, against the ability of procedures to reduce this risk, along with the 
potential for negative side effects. Understanding whether and how they do this 
involves understanding the forms in which women represent risk and the influence of 
these risk representations on choices. This review aims to better understand this. 
Breast Cancer Risk Factors 
The strongest risk factors for breast cancer are age and family history, with the latter 
largely mediated by specific identifiable gene mutations, such as the BReast CAncer 
(BRCA) 1/2 genes (McPherson, Steel, & Dixon, 2000). Other risk factors include: age 
of menstruation and menopause, age of first child, (McPherson et al., 2000), diet, 
alcohol consumption (Ferrero & Namer, 1994) and the use of oral contraception 
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(McPherson et al., 2000). Personal history of breast cancer also significantly increases 
a woman’s risk of developing a new breast cancer (Tuttle, Habermann, Abraham, 
Emory, & Virnig, 2007).  
Genetic mutations in the BRCA 1/2 genes can increase risk of developing breast 
cancer. Women who carry the genetic mutations and have multiple family members 
with the disease have an 80-90% lifetime risk of developing breast cancer (Easton, 
Bishop, Ford, & Crockford, 1993). Certain ethnic groups including Ashkenazi Jewish, 
Icelandic, Swedish, Hungarian, and French-Canadian have been found to have higher 
rates of the genetic mutation (National Comprehensive Cancer Network, 2008).  
Options Available for Breast Cancer Risk Reduction 
Women identified to be at increased risk of breast cancer can choose to access a range 
of risk-reducing procedures. Radiographic mammograms or more advanced screening 
through Magnetic Resonance Imaging (MRI) are available for some women (National 
Institute of Clinical Excellence [NICE], 2013). Screening can promote early 
detection, which can improve prognosis, but cannot prevent breast cancer. 
Mammographic screening also has a high rate of false positives that can often cause 
distress (Aro, Pilvikki Absetz, van Elderen, van der Ploeg, & van der Kamp, 2000).  
Chemoprevention through the provision of Selective Estrogen Receptor Modulators 
(SERMs), such as Tamoxifen, may be offered to postmenopausal women who are at 
high risk of developing breast cancer (Bao, Prowell, & Stearns, 2006; NICE, 2013). 
Tamoxifen can reduce incidence of estrogen receptive-positive invasive breast cancer 
by up to 43%, but has no impact upon estrogen receptive-negative breast cancer 
(Sestak, Cuzick, Evans, & Kwong, 2012). Tamoxifen increases incidence of 
endometrial cancer and thromboembolic events (Nelson et al., 2009).  
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Risk-Reducing Mastectomy (RRM) is the surgical removal of breast tissue, which can 
reduce breast cancer risk in women at high risk by approximately 90 to 95% (Rebbeck 
et al., 2004). The procedure can be offered bilaterally (BRRM), the removal of tissue 
from both breasts, or contralaterally (CRRM) to a breast that has been affected by 
cancer. RRM is irreversible and is associated with physical difficulties including pain 
and discomfort (Payne, Biggs, Tran, Borgen, & Massie, 2000) and difficulties relating 
to appearance and femininity (Hopwood et al., 2000). 
Risk-reducing bilateral salpingo-oophorectomy is the surgical removal of the ovaries 
and fallopian tubes, often offered to women with a BRCA 1/2 mutation. The 
procedure can reduce the risk of breast cancer by up to 50% (Bradbury & Oloparde, 
2007) and risk of ovarian cancer by 90-95 % (Domchek & Rebbeck, 2007). However, 
as with RRM, salpingo-oophorectomy is irreversible and surgery of any kind carries 
risk of infection and complications. Bilateral salpingo-oophorectomy also produces a 
premature surgical menopause that will cause infertility and difficulties associated 
with the menopause (Domchek & Rebbeck, 2007). 
Risk Perception and Decision-Making 
Risk perception is an individual’s personal understanding of risk and is seen as 
playing a key role in health decision-making (Skinner, Kreuter, Kobrin, & Strecher, 
1998). Early health decision-making theories were based on utilitarian principles, 
whereby people were expected to respond to dimensional perceptions of the 
likelihood and possible severity of potential outcomes and balance those perceptions 
with the advantages and disadvantages of remedial actions (Hochbaum, 1958; Rogers, 
1975, 1983; Weinstein, 1980,1993). Later views have been based on dual-process 
models, where heuristic modes of thought exist independently and compete with the 
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more deliberative modes described above. A number of heuristics have been proposed 
to play a role in decision-making, the most commonly studied being decisions that 
involve emotional responses to risk (Leventhal, Brissette, & Leventhal, 2003; 
Loewenstein, Weber, Hsee, & Welch, 2001; Slovic, Finucane, Peters, & MacGregor, 
2002). Later models have abandoned the dual-process approach, portraying risk 
perception as a function of the idiographic ways in which individuals reduce complex 
verbatim experiences to simpler meaningful representations (Reyna & Adam, 2003). 
Quantitative studies address the questions of how risk is perceived and how it 
influences decision-making through the prediction of decision outcomes and 
behaviour from theoretically derived measures of risk (Weinstein et al., 2007). 
Decision-making in primary and secondary breast cancer prevention is only weakly 
predicted by dimensional estimates of outcome likelihood and potential severity 
(Katapodi, Lee, Facione, & Dodd, 2004; Sivell et al., 2008; van Dijk et al., 2003). 
Decision-making also appears to be predicted by subjective states such as anxiety or 
vulnerability (Howard, Balneaves, & Botorff, 2009; Meiser et al., 2000; van Dijk et 
al., 2003). Quantitative analyses are, however, limited for two reasons. First, they 
reflect existing theory and are restricted in the extent to which they can be used to 
drive future theoretical development, and, second, it is difficult to discriminate 
between risk perceptions that are central to decision-making and those that are 
generated in response to researchers’ questions (Hawkes & Rowe, 2008). 
Qualitative approaches focus on participants’ accounts of their experiences and can 
potentially reveal how women perceive risk and how those perceptions guide their 
decision-making. The aim of this review was to conduct a synthesis of existing 
qualitative literature concerning how women with elevated risk for breast cancer 
DECISION-MAKING REGARDING RISK-REDUCING OPTIONS IN BREAST CANCER 
9 
 
perceive this risk and the potential benefits and risks of preventive interventions, and 
how these perceptions guide decision-making.   
The review will aim to answer two questions:  
 How do women at increased risk of breast cancer perceive risk?  
 What role do risk perceptions play in decisions regarding risk-reducing 
strategies? 
Method 
Eligibility Criteria 
Studies that qualitatively examined risk perception, defined as women’s subjective 
understandings of risk, were included. Studies were limited to those that included an 
adult woman sample and specifically addressed future breast cancer risk. Studies 
needed to state the sample as being at increased risk of breast cancer or identify 
membership of an established high-risk group. These include women who have 
established genetic (e.g. BRCA 1/2), or familial (including first degree relatives) risk 
factors or lifestyle related risk (e.g. overweight) and breast cancer survivors. Studies 
of women currently under treatment for breast cancer or associated symptoms were 
excluded. For question two, any methods aimed at risk reduction, including detection 
and prevention strategies, were included. Inclusion was limited to English language 
studies. No restrictions were placed on the date studies were published. For quality 
control, only peer-reviewed published studies were included.  
Search 
Search terms and alternatives were initially identified using several reviews relevant 
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to this area (Howard et al., 2009; Sivell et al., 2008) and then augmented by initial 
scoping searches (appendix 2). As the second review question is contingent upon the 
first question, additional searches were unnecessary. Records of the number of results 
per search term were recorded (appendix 2 for example). 
Search Strategy 
Keywords relevant to breast cancer (“breast cancer” OR “breast carcinoma” OR 
“breast neoplasm”) AND risk perception (“risk perception” OR “risk understanding” 
OR “perceived risk” OR worry OR dread OR “anticipated emotion” OR “anticipatory 
emotion” OR emotion* OR vulnerability) AND qualitative methodology (qualitative 
OR “Grounded Theory” OR IPA OR “Interpretative Phenomenological Analysis” OR 
“Thematic Analysis” OR “Content analysis” OR “Narrative Analysis” OR 
“Conversation Analysis” OR “Discourse Analysis” OR interview* OR “focus 
groups”) were searched.  
Information Sources 
The electronic databases PsycINFO (1879-2013), Medline (1948-2013), Web of 
Knowledge (1900-2003), and Scopus (1960-2013) were searched for relevant 
published literature. References from previous systematic reviews were also reviewed. 
Searches were combined and duplicates removed before study selection. Hand 
searches were also conducted of key papers and the reference lists of the included 
articles.  
Study Selection  
Using the electronic databases, search terms were identified from titles, abstracts and 
keywords. Following the search strategy, identified studies were assessed for 
inclusion. Initially HF screened all identified titles and then the abstracts of selected 
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titles for potential inclusion. Following this, full copies of the studies identified as 
potentially relevant were read and an assessment of whether they met the inclusion 
criteria was made. At times when it was unclear whether or not the studies should be 
included, a second opinion was sought (SB) and a joint decision reached.  
Reference lists and reasons for exclusion of studies were kept. Point of exclusion and 
the reasons for exclusion at each stage were recorded (appendix 2). The process of 
study selection is presented using the Preferred Reporting Items for Systematic 
reviews and Meta Analysis ([PRISMA] Moher, Liberati, Tetzlaff, & Altman, 2009) 
flow diagram in figure 1.  
 
 
 
 
 
 
Figure 1. PRISMA flow diagram displaying the article selection process. 
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Quality Assessment 
Although a decision was made not to exclude studies based on quality, the Critical Appraisal 
Skills Programme (CASP) tool (CASP, 2013) was used to gauge study quality. The CASP for 
qualitative research provides a quality assessment system based upon conceptual logic and 
methodological adequacy (CASP, 2013). Studies are evaluated on a ten-point system 
pertaining to the adequacy of design, sampling, analysis and interpretation (appendix 3).  
Data Synthesis 
In line with other systematic reviews with similarly interpretative aims (e.g. Sivell et al., 
2008) a narrative synthesis was chosen as the method of synthesis. Synthesis was performed 
at the level of themes reported in the studies, although differing conclusions to the study 
authors were sometimes drawn in the light of themes from other studies and risk perception 
theory. To improve the transparency of the process, points 2-4 of Popay et al.’s (2006) 
recommendations were followed. Specifically, these included developing a preliminary 
synthesis as a working model, interrogating the model in terms of its consistency and 
inconsistency with the source data, and reviewing the robustness of the synthesis process 
itself. The synthesis process was designed to retain the individuality of each study whilst 
exploring commonalities and contradictory explanations of risk perception and its role in 
decision-making.  
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Table 1:  
Summary of Included Studies 
Reference Country Sample characteristic of 
interest 
Sample Data Collection 
Method 
Analysis Aim(s) 
Altschuler  
and Somkin 
(2005) 
 
USA Eligible for genetic testing 
(identified as high risk by 
Gail model) and accepted or 
declined 
 
 
n=51 
Age: 40-80+ yrs 
Ethnicity: 93.4% White, 2.5% African 
American, 2.0% Latina, 2.1% other 
FH: unclear 
PH: unclear  
BRCA: not stated 
Semi-structured 
interview 
Grounded theory 
 
Understand why women at similarly high calculated 
risk, made different choices about whether or not to 
join a hormonal therapy trial 
Beesley, 
Holcombe, 
Brown, and 
Salmon (2013) 
UK Women considered for 
CRRM 
n= 60  
Age: 24-68yrs 
Ethnicity: not stated 
PH: all 
FH: not stated 
BRCA: not stated 
Case series Constant 
comparative 
Understand decision-making in CRRM. (b) Identify 
factors that influence these decisions 
Bennett, 
Parsons, Brain, 
and Hood 
(2010) 
UK Intermediate risk of BC 
with range of BC worry 
scores following risk 
assessment   
 
n=30 
Age: 48.1 mean (range not stated) 
Ethnicity: not stated 
FH: all   
PH: not stated 
BRCA: unknown 
Semi-structured 
interview 
Thematic analysis Understand experience of taking part in risk 
assessment, (b) living at risk, (c) coping strategies 
Chalmers and 
Thomson 
(1996) 
Canada FDR with BC n=55 
Age: 20-69yrs 
Ethnicity: not stated 
FH: all 
PH: none 
BRCA: not stated 
Semi-structured 
interview 
Latent content 
analysis and constant 
comparison 
techniques within 
symbolic interaction 
framework.   
Explore and describe meaning of risk experience in 
women with FDR with BC 
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Dagan and 
Goldblatt 
(2009) 
Israel  Asymptomatic BRCA 1/2 
carriers 
n=17 
Age: 37-55yrs 
Ethnicity: Israeli Ashkenazi Jewish 
PH: none 
FH: all  
BRCA: all 
Semi-structured 
interview 
Thematic content 
analysis 
How gave meaning to family scripts and dialectic 
between being concurrently healthy and at high risk 
for BOC. (b) Ways of coping with risks 
Hallowell, 
Foster, Eeles, 
Ardern-Jones, 
and Watson 
(2004) 
UK Treated for  
BOC and completed genetic 
testing 
n= 30 
Age: 39-71yrs 
Ethnicity: not stated 
PH: 27  
FH: 26 FDR 
BRCA: 10 positive, 12 inconclusive, 8 
awaiting results 
Semi-structured 
interview 
Constant 
comparative  
Investigate perceptions and reactions to genetic risks. 
Establish information and support needs before and 
after result  
Hoskins, Roy, 
and Greene 
(2012). 
USA Young BRCA carriers  n=60,  
Age: 21-36yrs 
Ethnicity: 3% Hispanic, 97% White, 
20% Jewish 
PH: not stated 
FH: not stated 
BRCA: all 
Semi-structured 
telephone interview 
Grounded theory Understanding of lived experiences of women who 
learn early in life that carry BRCA1/2 mutation. (b) 
Characterise complex ways BRCA1/2 young women 
think, behave, and create meaning 
Kelly (1980) USA Maternal history of BC n=39 
Age: 28-73yrs 
Ethnicity:  34 White, 3 Oriental, 2 Black  
PH: none 
FH: all 
BRCA: not stated 
Semi-structured 
interview 
Grounded theory Determine needs, concerns, and health practices 
pertaining to BC. (b) Explore what subjects thought, 
felt, and did about BC and breast health care 
Kenen, Ardern-
Jones, and 
Eeles (2003) 
UK FH of BC, do not know if 
family have genetic risk 
n=21 
Age: 24-61yrs 
Ethnicity: not stated 
PH: none 
FH: all  
BRCA: all unknown 
Semi-structured 
interview 
Thematic How healthy women from families with a history 
breast and ovarian cancer live with their heightened 
awareness of risk 
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Note. n = number of participants; FH = family history of breast cancer; PH = personal history of breast cancer; BRCA = BReast CAncer gene 
status; CRRM = contralateral risk reducing mastectomy; BC = breast cancer; FDR= first degree relative; 2
nd
 DR= second degree relative; BOC= 
breast or ovarian cancer.
Keogh, 
McClaren, 
Apicella, and 
Hooper (2011) 
Australia 1 FDR or 2nd DR diagnosed 
with BC before 50yrs. 
BRCA1/ 2 not identified in 
family 
n=24  
Age: 35-70yrs 
Ethnicity: not stated 
FH: all 
PH: none 
BRCA: all unknown 
Semi-structured 
interview 
Thematic Describe  (b) how it is related to screening behavior. 
Raveis and 
Pretter (2005) 
USA Caring for mother with BC  n=50. 
Age: 21-62yrs 
Ethnicity: 70% White, non-Hispanic, 
24% Hispanic 4% Black, non-Hispanic  
PH: not stated 
FH: all  
BRCA: not stated 
Semi-structured 
interview 
Content analysis Understand daughter’s experience/ reaction and 
personal risk and vulnerability following mothers BC 
diagnosis.  
Robertson 
(2000) 
 
 
Canada Attended Breast Health 
Clinic, aged 30 -50 (pre-
menopausal); no PH of BC  
 
Only presents data of 
women indicated to be at 
increased risk by Gail 
assessment tool 
n=20 
Age: 30-50yrs 
Ethnicity: mostly northern European  
PH: none 
FH: not stated 
BRCA: excluded women who had 
undertaken gene testing 
Semi-structured 
interview  
Thematic Explore notion of 'phenomenology of risk' to explore 
women's accounts of their own individual risks for BC 
Sheinfeld 
Gorin and 
Albert (2003) 
USA At least one close female 
relative diagnosed with BC  
n=26. 
Age Normalizer 49yrs, Adopter 42yrs 
(mean)  
Ethnicity: majority white 
PH: not stated 
FH: all  
BRCA: suggest ‘some’ but no % 
Semi-structured 
interview 
Thematic 
 
Understanding of the effect of risk perception on 
screening adherence. (b) Explore risk in a woman’s 
natural language 
Werner- Lin 
(2007) 
USA Young age (22-36) BRCA 
positive 
n= 22 
Age: 22-36 
Ethnicity:  White, mixed Eastern/ 
Western European 
PH: none 
FH: 20    
BRCA: all 
Semi-structured 
interview 
Listening guide Explore connections between family history and 
beliefs about susceptibility. (b) Understanding of how 
family histories/experiences with health care 
professionals integrated to inform beliefs. 
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Results 
Summary of Included Studies 
Table 1 summarises the 14 included studies. The studies often defined their sample by shared 
risk factors and some by statistical risk estimates. Despite women in the samples having 
similar levels of objective risk, there was great variation in how they discussed risk and the 
level of emotion they described. This suggests that risk perception and level of emotion is 
individualised and shaped by more than objective risk estimates. 
Results of Quality Assessment 
All of the 14 studies included were rated as valuable using the CASP tool (CASP, 2013). 
However several limitations pertaining to data collection were identified (see appendix 3 for 
full breakdown). With the exception of two studies (Chalmers & Thomson, 1996; Dagan & 
Goldblatt, 2009), none of the studies provided a rationale for the interview questions asked, 
appearing to be guided by topics of interest. All but two studies (Hoskins et al., 2012; 
Robertson, 2000) provided the general themes of the interviews allowing some context from 
which to assess the findings. However only one study (Werner-Lin, 2007) provided example 
questions, preventing assessment of the potential impact of framing effect (Hawkes & Rowe, 
2008). In addition, across the studies there was minimal discussion regarding the impact of 
the researcher on the study, including in formation of the research question and the impact on 
data collection. This becomes relevant when considering the extent to which women regarded 
the researcher as separate to their health provider and whether they felt required to justify 
access to services, possibly through the use of highly emotive language. It is possible that 
failure to reflect on, or at least discuss the role of the researcher reflects an expectation that 
identification of a method is adequate for the reader to understand the position that the 
researcher has taken; this is not the case (Chamberlain, 2000). 
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How do women at increased risk of breast cancer perceive risk? 
Dimensional Views of Risk 
Several studies reported that some women discussed dimensional or scalar risk estimates 
such as likelihood or severity. All women attending a high-risk clinic (Robertson, 2000) 
knew population risk figures and many reported attempting to create their own personal risk 
estimate, some in the form of a dimensional (numeric) estimate. Further, Beesley et al. (2013) 
found that out of a sample of 60 breast cancer survivors, five reported dimensional risk 
estimates. 
The capacity to report numeric values does not mean that women endow the same estimates 
with the same meaning. Even when women are able to provide a numerical risk estimate, 
they can interpret the same estimate differently, and these interpretations appear to be used in 
decision-making. Keogh et al. (2011) uses the example that ‘one in three’ odds can mean two 
distinctly different things; with one interpretation being that she is not the ‘one’, whilst 
another understanding this to mean she will definitely die of breast cancer.  
Categorical Perceptions of Risk 
More women employed non-dimensional conceptualisations of risk. These are described 
either as probability-based categories such as ‘certainty’ (of getting cancer), or being ‘at risk’ 
(Chalmers & Thomson, 1996; Robertson, 2000), or in terms of membership of subjective 
categories such as ‘vulnerable’ (Beesley et al., 2013; Raveis & Pretter, 2005). This finding 
appears to be consistent across a range of sample types and data analysis methods, and 
women were often explicit about using these subjective categories. A common finding across 
studies was that women described their breast cancer risk as being ‘certain’. This finding 
appears well supported, with evidence being found in some women whose mothers had been 
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diagnosed with breast cancer (Kelly, 1980) and in some women who had first or second 
degree relatives with cancer (Chalmers & Thomson, 1996; Keogh et al., 2011). Werner-Lin 
(2007) also describes that, following BRCA testing, women felt that they were on a ‘path 
towards cancer’ and that without action they would experience the disease.  
Worry 
To different degrees, the role for emotion in relation to breast cancer risk was highlighted 
across all the included studies. This was usually characterised by descriptions of ‘worry’, 
which was described in both cognitive and emotional terms as aversive, ever-present, 
overwhelming and resistant to reassurance or counterargument. Emotion was less commonly 
described in terms of emotional states such as ‘distress’ or ‘fear’ although these were used 
either interchangeably with worry, or to describe the outcome of a process of worry.   
Worry was characterised by a constant awareness. Women described the threat of breast 
cancer as a ‘constant companion’ (Dagan & Goldblatt, 2009; Robertson, 2000) and feeling 
chronically threatened by it (Kelly, 1980). Worry was also resistant to reassurance by 
explanation of the level of objective risk or by routine examinations or investigations 
(Beesley et al., 2013).  
Emotion, though, may be argued to be a consequence rather than a component of risk 
perception. Evidence against this view comes from several studies that describe emotion in 
terms that suggest it is an independent component of the risk perception process. Several 
studies (Altschuler & Somkin, 2005; Keogh et al., 2011) indicate that although women knew 
‘intellectually’ they were at increased risk, this information did not cause them to worry; 
possibly suggesting that ‘intellectual knowledge of risk’ and worry are related but distinct 
entities in their minds. Beesley et al. (2013) make a similar point, suggesting that worry 
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exists where women do not claim to consider dimensional or categorical representations of 
risk. 
The ‘Lens’ of Family Experience  
The studies showed that family experience of breast cancer framed and influenced the 
experience of risk. Several studies show that family experiences established a template that 
women used to consider risk, creating and organising expectations regarding their own 
futures. These templates were shaped by the family’s experiences of breast cancer, not simply 
by the presence or absence of a family history of the disease. The age of the first family 
member diagnosed with the disease was highlighted as relevant for many women’s 
perception of risk. Dagan and Goldblatt (2009) referred to this as the ‘family clock’ and 
Werner-Lin (2007) discusses a ‘danger zone’. Remaining healthy at the age at which their 
mother developed the disease provided a source of hope for future health (Dagan & Goldblatt, 
2009) and was regarded as a benchmark that lessened women’s anxiety about developing the 
disease (Altschuler & Somkin, 2005).  
Breast cancer in the family also acts as a model of how to respond to breast cancer risk. 
Hoskins et al. (2012) suggests that the young BRCA carriers understood risk through the 
‘lens’ of family history through which they weighed ages, sites, and stages at which relatives 
were diagnosed when considering whether they might be at risk themselves. The results 
suggest that mothers’ coping (Dagan & Goldblatt, 2009; Kelly, 1980), the outcome of the 
disease (Dagan & Goldblatt, 2009; Kenen et al., 2003) and time since their relative’s 
diagnosis (Kenen et al., 2003) can shape a woman’s understanding of the disease and its 
saliency. Further, that the age and developmental stage of the woman when their relative 
developed breast cancer (Chalmers & Thomson, 1996; Dagan & Goldblatt, 2009) and the 
nature of their relationship and the role they played in caring for their sick relative also 
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influences women’s risk perceptions (Dagan & Goldblatt, 2009; Kenen et al., 2003). 
Additionally, women’s identification with their family member with breast cancer (Bennett et 
al., 2010; Chalmers & Thomson, 1996; Raveis & Pretter, 2005), and perceived similarity to 
that family member (Kelly, 1980; Werner-Lin, 2007), can also shape risk perception. 
Several studies suggest that family history can create a shift in the way women perceive 
themselves, for example by destroyed beliefs of immunity (Raveis & Pretter, 2005) and 
increasing awareness of her own vulnerability (Kelly, 1980; Raveis & Pretter, 2005).  
Chalmers and Thomson (1996) see the family experience as providing a view of risk that 
women could move away from through a process of deliberation. The authors describe this 
process of individuation away from their family experience towards their own ideas 
concerning risk through three phases. The first being the process of ‘living’ the breast cancer 
experience through their relative with the disease. The second stage involves the development 
of a risk perception. The third being a process of ‘putting risk in its place’ and integrating risk 
into a view of oneself.   
What Role do Risk Perceptions Play in Decisions Regarding Risk-Reducing Strategies? 
Emotion is a Proximal Determinant of Decision Outcome 
Women were often explicit in describing their decision-making goals in terms of managing 
worry, anxiety or vulnerability, rather than cancer risk (Beesley et al., 2013; Robertson, 
2000). Robertson (2000) found that women managed their anxiety about being 'at-risk' for 
breast cancer by managing their bodies and adhering to a low-risk lifestyle. Beesley et al. 
(2013) concludes that vulnerability motivates women to seek CRRM and goes further to 
suggest that this appeared to be more relevant than objective risk understanding in the 
decision-making process. Others cited worry, fear or anxiety as proximal determinants of 
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decision-making across a range of risk-reducing options (Altschuler & Somkin, 2005; 
Bennett et al., 2010; Dagan & Goldblatt, 2009; Kelly, 1980; Kenen et al., 2003; Keogh et al., 
2011; Sheinfeld Gorin & Albert, 2003). 
Altschuler & Somkin (2005) reported higher rates of anxiety in women who opted for 
chemoprevention compared to those who refused, and Bennett et al. (2010) found that 
women who had high levels of breast cancer worry emphasised the need for mammographic 
screening and had a lower reliance on breast self-examination when compared to those who 
had lower breast cancer worry. Sheinfeld Gorin and Albert (2003) propose that worry is a key 
discriminator between ‘risk acceptors’ and ‘normalizers’ and suggest that these groups act on 
risk in different ways, with acceptors making lifestyle choices to take advantage of their 
perceived shortened lifespan.  
Existence of Risk Factors 
Several studies suggest that women become motivated to take precautions when they learn of 
a risk factor that applies to them personally. This appears to reflect the existence of the risk 
factor and its personal relevance, rather than any sense of either level of risk attributable to 
that factor or aggregate risk. Kelly (1980) suggests that women felt a need to learn as much 
as they can about risk reduction because they do not wish to unknowingly miss opportunities 
to reduce risk. A number of studies underline women’s attempts to engage in healthier 
lifestyles as a method of reducing their risk. In one of the groups conceptualised by Keogh et 
al. (2011), there was an attitude of being ‘concerned about cancer risk, so do something’, 
characterised by a belief that action could reduce risk and resulting in women opting for a 
healthy lifestyle, reducing stress and monitoring their bodies. Additionally, Kenen et al. 
(2003) highlighted that many women believed that eating a healthy diet, reducing stress or 
having the ‘right attitude’ might help ward off cancer, or was at least worth doing. Further, 
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Robertson (2000) suggests that women develop an 'at-risk' consciousness which results in 
women, to different degrees, engaging in health practices as 'self-care' strategies for 
managing their perceived risk and when they don’t, they exhort themselves to do so.  
Discussion 
Summary 
This qualitative synthesis was designed to establish the terms in which women at increased 
risk of breast cancer described this risk and how their mental representations of risk 
influenced choices of risk-reducing interventions. Women perceived risk in several ways, 
with some evidence that women represent risk in a dimensional way, and more evidence for 
categorical representations of risk. Women often described states of worry or emotional states 
such as fear; characterised by constant awareness, a chronic state of threat and negative 
emotion. Some women reported this worry as being independent to their knowledge of their 
risk status and resistant to reassurance. A further way of perceiving risk appeared to be 
experiential, where women directly inferred risk from their family experiences and some 
evidence that through active deliberation women could individualise this risk (Chalmers & 
Thomson, 1996). Women stated that they made risk reduction choices to reduce aversive 
states such as worry or because they saw specific risk factors that could be reduced through 
behavioural change. The degree to which this behaviour could reduce risk seemed irrelevant 
to women’s uptake of risk-reducing behaviour.  
Empirical and Theoretical Relevance 
Utility theories conceptualise risk in terms of dimensional estimates of outcome likelihood and 
severity, and decision-making in terms of the extent to which choices can reduce these risks 
(Hochbaum, 1958; Rogers, 1975, 1983). These theories appear to be of limited use in women at 
increased risk of breast cancer as only a few women were found to use dimensional likelihood 
estimates. This begs the question of why empirical tests often support these models, albeit often 
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with small effect sizes (van Dijk et al., 2003; Katapodi et al., 2004).  It is surmised that, either 
participants in quantitative studies construct a dimensional estimate from existing 
representations for the specific purpose of answering the question, or that they held a 
dimensional estimate at some point but that these were not prominent in the decision process. 
Women’s use of subjectively defined categories fits with the findings of Lippman-Hand and 
Fraser (1979) who suggest that people interpret risk in a binary form, Margolis (1996) who 
suggests that people view risk as either significant, or negligible, and Cameron, Sherman, 
Marteau and Brown’s (2009) concept of ‘chunking’. This finding also appears consistent with 
Loewenstein et al.’s (2001) suggestion that uncertain situations often promote responses 
which have binary characteristics and that neglect elements of probability. Women’s 
categorisation of risk means that their thinking about risk will be influenced by the meanings 
that they attach to category labels such as ‘low’, ‘moderate’ or ‘high’. These labels will be 
idiographic, with potential variance in meaning between individuals (Brown, Nowlan, Taylor, 
& Morley, 2013). Thus, understanding categorical risk perception will entail determining 
what women mean by the categories that they use. It is also significant that categorical risk 
perceptions were generally not mentioned by women as being responsible for their decision-
making. Thus, these categories may either not be relevant considerations, or possibly, are not 
proximal to the decision outcome. 
In the majority of studies, women discussed risk with reference to fear, worry and anxiety. It 
is possible that women were worried and fearful because they were at increased risk; that 
emotion was the result of an increased risk perception or increased risk status (Sivell et al., 
2008). However, the reported discrepancy between emotional and intellectual understandings 
of risk, suggest that these may be distinct ways of perceiving risk. This suggestion seems 
further supported by the finding that emotion was resistant to reassurance by explanation 
about level of risk.  
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The finding that worry seems to play a role in how risk is perceived and acted on appears 
largely compatible with more recent theoretical developments, which suggest that people 
process information using two modes: experiential and deliberative (dual process models, 
Leventhal et al., 2003; Loewenstein et al., 2001). The deliberative system emphasises 
cognitive representations and the experiential system is affective, intuitive and automatic 
(Slovic & Peters, 2006), which appears to fit with women’s descriptions.  
However, dual process theories suggest a stronger role for dimensional or categorical 
estimates of risk in decision-making than found in this review. We suggest two reasons why 
emotive representations, such as worry, may dominate. First, breast cancer is an inherently 
emotive topic, particularly amongst women who have personal or vicarious experience of it. 
Second, dual process models suggest that emotive modes will dominate when people lack 
resources to engage in deliberative thought (Loewenstein et al., 2001), as may happen when 
women experience negative emotions or feel challenged by the complexity of decisions that 
they are faced with. 
Women appeared to understand and respond to risk using a script defined by experience with 
breast cancer. For many, this was a family script, the narratives of which, rather than simply 
the presence of cancer in the family, influenced how risk was understood. It is possible that 
family experience plays a greater role in the perception of risk at the initial stages of 
formation of an individual risk perception (Chalmers & Thomson, 1996). The importance of 
family history in shaping risk perceptions is also highlighted in a sample at increased genetic 
risk of disease (Sivell et al., 2008) and fits with the suggestion that people use their personal 
experience as a standard by which to assess risk (Grenning, Dollinger, & Pitz, 1996), 
conceivably through the construction of mental scenarios (Gregory, Cialdini, & Carpenter, 
1982). The findings also appear to be in line with the concept of ‘experiential knowledge’ (a 
process that emerges and is shaped by the identity, circumstances, experiences and interests 
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of the knower) that impacts upon women’s perceptions of their cancer risk (D’Agincourt-
Canning, 2005).  
The review focuses on women’s perceptions of risk and the aspects of risk perception that 
women feel are relevant to their uptake of risk-reducing options. It is of note however, that 
risk perception makes up only one of a range of factors suggested by the empirical literature 
to be relevant to this decision-making process. A systematic review of the quantitative and 
qualitative data in this area (Howard et al., 2009) splits these relevant factors into three 
categories. Firstly, physical and medical factors such as BRCA status, previous breast cancer 
history, age, parity and menopausal status are evidenced to influence decision-making in this 
area. However, the review highlights that at times this evidence is mixed and somewhat 
contradictory. Secondly and somewhat in line with the findings of this review, there is 
evidence that psychological factors including cancer worry and risk perception play a role in 
the uptake of a range of risk-reducing options. Finally, Howard et al. (2009) highlight that 
social context, including patterns and personal experience of cancer in the family, alongside 
family obligations such as holding a caring role within the family, can in some cases, impact 
upon this decision-making process. 
More broadly than the social factors identified within the Howard et al. (2009) review, 
international variation in uptake of risk reducing options (Metcalfe et al., 2008) may suggest 
a cultural difference in the acceptability of risk-reducing options, both for women and health 
care professionals (Julian-Reynier et al., 2001). Variation in the availability of different risk-
reducing options may also play a role in women’s decision-making process (Metcalfe et al., 
2008). 
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Strengths and Limitations of the Review 
The review offers a unique synthesis of qualitative data regarding risk perception and 
decision-making in a sample of women at increased risk of breast cancer. The review aims to 
address this gap in understanding in a rigorous way, using systematic search methods and 
drawing on guidelines (Popay et al., 2006) to increase the transparency of the narrative 
synthesis process. Additionally, the use of the CASP (CASP, 2013) tool, has allowed the 
quality of studies to be assessed in a consistent and replicable way.  
Qualitative data were selected for synthesis as it allows new insights into risk perception 
theory and the data synthesised appears to offer findings of empirical and theoretical value. 
However, we are mindful that important phenomena are often implicit, otherwise concealed 
from participants’ insights or deliberately or inadvertently withheld (Knox & Burkard, 2009). 
The synthesis therefore provides a useful, but partial understanding, which needs to be 
considered in light of the available quantitative literature; particularly research that highlights 
the range of factors that potentially influence decision-making in this area (Howard et al., 
2009).   
As few studies specifically aimed to examine risk perception, the review is restricted because 
data in many studies were collected to examine different research questions. In particular, it 
is unwise to make conclusions about the absence of phenomena because studies may not have 
been specifically designed to capture them. With the exception of Kenen et al. (2003), there 
is limited interpretation of data within the framework of health decision theory. Whilst 
participants in these studies have spontaneously provided suitable material for this review, 
theory development may be aided by investigations that involve decision-making theories. 
Practical Implications and Future Research 
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The findings of the review alongside recognition that people experience difficulty in 
understanding and using likelihood information (Lipkus, Samsa, & Rimer, 2001) and may not 
even attempt it (Schneider, 2001), indicate that we should not expect women to have a 
detailed dimensional estimate of risk and to understand the proportions by which each risk-
reducing option will reduce risk.  
The extent to which women should be encouraged to form this understanding and use 
deliberative processing styles is a contentious one. Decision aids used to improve the quality 
of decision-making in this sample are usually based on the premise of traditional utility 
models, with the expectation that women are willing and able to deliberatively weigh up their 
decision. However, some researchers have suggested that reliance on affect is necessary to 
form good decisions (Slovic & Peters, 2006) and others have highlighted the potential harm 
that can be caused by encouraging the use of deliberative processing styles (De Vries, 
Fagerlin, Witteman, & Scherer, 2013). Of course, the conceptualisation of a ‘good’ decision 
alluded to in the above work is derived from experimental studies where ‘good’ decisions are 
defined by the methodology used. In real-life medical decisions, determining whether 
decisions are ‘good’ is more difficult and likely to be defined by process rather than outcome 
(Elwyn & Myron-Schatz, 2009). Thus, the question of whether heuristically-led decision-
making leads to ‘good’ decisions, and how these processes can be improved, in practice 
requires the identification of criteria for decision-making that accept that patients will make 
decisions heuristically (Elwyn & Myron-Schatz, 2009).  
Thus, further research, particularly qualitative studies that set out specifically with the aim of 
understanding the concept of risk perception, would be helpful alongside greater discussion 
of the relative weighting of different aspects of risk perception in decision-making. Greater 
research is also needed in the value of processing information and decision-making using 
deliberative and affective styles.   
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Abstract 
Risk-Reducing Mastectomy (RRM) is a surgical procedure aimed at reducing risk of breast 
cancer. RRM can have a range of side effects and questionable risk reduction benefits, 
making it a controversial option.  Previous research using a case series design has indicated 
that women may be driven to access RRM by a sense of vulnerability and a wish for cosmesis. 
This study aimed to explore how women made decisions regarding RRM using a qualitative 
research design. Using a semi-structured interview, 12 women provided their experience of 
making decisions regarding RRM. Results suggest that women’s decisions to undergo RRM 
was driven by fear of breast cancer and the belief that they should do all they can to reduce 
risk, not by a utility-based comparison of risks of cancer and side effects of RRM. Women 
reported engaging in deliberative decision-making strategies, but these were seen as 
justifications for a decision that had already been taken.  These findings provoke the question 
of whether women’s decisions should be accepted on the basis that negative affect reduction 
is a valid and viable goal in autonomous patient decision-making, or whether utilitarian 
decision-making ought to be encouraged.  
 
 
 
 
 
 
Keywords: Risk-reducing mastectomy, decision-making, breast cancer, qualitative.  
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How Women at High Risk of Breast Cancer Perceive Risk and Make Decisions 
Concerning Risk When They Choose Risk-Reducing Mastectomy 
 
Currently, approximately one in eight women in the United Kingdom will develop breast 
cancer in their lifetime (Cancer Research UK [CRUK], 2013) and two in ten women 
diagnosed will not survive over five years (CRUK, 2013). For many, the diagnosis and 
treatment of the disease has a multitude of negative physical, psychological and psychosocial 
consequences that can continue long after treatment is complete (Amir & Ramati, 2002; 
Bower, et al., 2000; Bradley, Bednarek, & Neumark, 2002). Individuals’ breast cancer risk 
can be estimated with some degree of confidence in women who both have and have not 
experienced the disease. This information can then be used to guide access to preventative 
options.  
In the UK, women identified to be at ‘high risk’ of breast cancer can choose to opt for risk-
reducing mastectomy (RRM), the surgical removal of healthy breast tissue to reduce risk 
(National Institute of Clinical Excellence [NICE], 2013). Contralateral RRM (CRRM) 
usually occurs in the opposite breast to which cancer has occurred. Bilateral RRM (BRRM) is 
mastectomy of both breasts; usually in women who do not have a personal history of the 
disease, but also when breast tissue remains from previous treatment. The magnitude of 
RRM’s risk reduction capabilities increases as estimates of objective risk increase; in some 
cases reducing risk by up to 95% (Rebbeck et al., 2004). However, the precise survival 
benefits of the procedure remain unclear (Lostumbo, Carbine, Wallace, & Ezzo, 2004; 
Sestak, Cuzick, Evans, & Kwong, 2012).  
RRM can have negative consequences, making it a controversial option (Drife, 1992; 
Stefanek, Hartmann, & Nelson, 2001). Pain (Payne, Biggs, Tran, Borgen, & Massie, 2000) 
and difficulties relating to appearance and femininity (Hopwood et al., 2000) have been 
DECISION-MAKING REGARDING RISK-REDUCING OPTIONS IN BREAST CANCER 
 41 
reported. Surgical complications and reoperations are also common (Gabriel et al., 1997). 
Women, in 14% of cases were found to regret their decision to undertake CRRM (Frost et al., 
2005) a figure that rises to 19% in relation to BRRM (Frost et al., 2000). Thus, when making 
decisions regarding RRM, consideration needs to be given to the risk of future breast cancer, 
the extent to which this risk can be reduced by RRM, and the risk of side effects and 
complications. Given the importance and magnitude of this decision, understanding women’s 
decision-making process is vital. 
Decision-Making Regarding RRM 
Utilitarian risk decision-making models suggest that people make decisions about risk by 
estimating the likelihoods and values of differing outcomes then logically integrating these to 
achieve decisions (Hochbaum, 1958; Rogers, 1975, 1983; Weinstein, 1980, 1993). In 
research investigating RRM decision-making, evidence that higher dimensional risk 
perception is associated with greater uptake of the RRM in hypothetical and actual decision-
making situations (Howard, Balneaves, & Botroff, 2009; Kataopdi, Lee, Facione & Dodd, 
2004; van Dijk et al., 2003) appears to be consistent with utilitarian models. However, the 
role of dimensional risk perception in uptake of RRM has been questioned (Appleton, Fry, 
Rees, Rush, & Cull, 2000; Hoskins, Roy, & Greene, 2012), with a recent review concluding 
that the evidence for the effects of perceived risk on the use of services (including RRM) is 
weak (Sivell et al., 2008).  
Cancer related distress, worry or anxiety has also been associated with higher uptake of RRM 
in quantitative (Howard et al., 2009; Meiser et al., 2000; Stefanek, Helzlsouer, Wilcox, & 
Houn, 1995; van Dijk et al., 2003) and qualitative (Hoskins et al., 2012; Howard et al., 2009) 
research. Evidence for the role of emotion in uptake of RRM appears to support dual-process 
theories of health decision-making, which proposes that people process and act on risk using 
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two distinct modes of thinking: deliberative and experiential (Peters, McCaul, Stefanek, & 
Nelson, 2006). Whilst the deliberative system is much like the systems proposed by 
utilitarian models, the experiential process is fast and intuitive (Peters et al., 2006). 
Mixed and at times weak evidence to support current theory may be partly due to a 
predominance of quantitative literature in the area (Hawkes & Rowe, 2008).  Lack of 
qualitative literature prevents understanding of the factors that women feel are important to 
their decision-making process and may have limited theoretical development. Additionally, 
as very few studies link their findings to health theory, the ability to draw conclusions that 
could lead to theory advancement is limited.  
A recent qualitative study by Beesley, Holcombe, Brown, and Salmon (2013) appears to 
suggest a stronger position for the role of emotion in decision-making than in previous 
research. The study concludes that quantitative risk perception played little or no role in 
women’s decision-making process; the decision to undertake CRRM was largely driven by 
an overriding sense of vulnerability and an awareness that risk existed. The study highlights 
that women explicitly stated that they did not consider risk in a dimensional way, nor did they 
consider the risks of side effects. These findings appear to contradict both utility and dual-
process decision-making theories because this sense of vulnerability represents the dominant 
way in which women appraise risk. These findings create a tension between whether 
women’s decisions should be accepted on the basis that negative affect reduction is an 
acceptable goal in autonomous patient decision-making, or whether efforts should be made to 
encourage more utilitarian decision-making. However the conclusions are limited by a case 
series design based on clinical notes, a sample limited to women obtaining CRRM and not 
BRRM, and lack of links to theory. It is important to examine whether these findings hold up 
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when data is directly provided by women considering both CRRM and BRRM and 
considered in the light of current risk perception theory. 
Rationale and Aims 
Understanding gained from current theory does not appear to adequately reflect how women 
actually make RRM decisions. In particular, the findings of Beesley et al. (2013) suggest that 
women use RRM as a means of reducing the negative affect associated with vulnerability to 
cancer, raising tension about the suitability of this approach to decision-making.  
It is possible that a predominance of quantitative literature in the area may have stifled 
theoretical development that could more adequately explain Beesley et al.’s (2013) findings, 
and more broadly, decision-making in this area. In an effort to facilitate the development of 
new theoretical approaches, this study will provide a much-needed qualitative contribution to 
our understanding of how decisions to undergo RRM are made in a sample of women who 
have chosen to do so. By directly interviewing women rather than examining clinical records, 
the study will overcome the methodological limitations of the Beesley et al. (2013) study, 
allowing greater understanding of the decision-making process from the decision maker’s 
perspective.   
The study has two aims: 
 To describe, using in-depth interviews, how women make decisions regarding RRM. 
 To identify implications of the findings for the role of decision support for women 
facing RRM decisions and for psychological theory.  
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Method 
Sample 
A consecutive sample of twelve women was recruited from a large breast unit in North West 
England.  All of the women approached regarding participation in the study agreed to take 
part, of which, all then went on to be interviewed.  
Recruitment aimed to reflect the range of women who opted for RRM at the breast unit and 
therefore no limits were placed on type of surgery (CRRM or BRRM) or previous experience 
(personal history of breast cancer or not). This information was collected alongside age, 
family history of breast and other cancers, BRCA status, highest qualification achieved, and 
employment status. The 100% response rate provides confidence that the sample was 
sufficiently broad to represent the range of women who attended the unit. A condition of 
entry into the study was that women had to have made their decision to have RRM and have 
no plans to revisit the decisions in the subsequent three months. Women who had surgery 
were interviewed within three months of surgery.  
Data Collection 
The study was granted NHS ethical approval (13/NW/0421). Staff at the breast unit (breast 
care nurses, surgeons, psychologists) provided potential participants with information about 
the study. If women were interested and agreed to be contacted they were given an 
information sheet (appendix 5), which included all relevant ethical information (appendix 6 
for additional detail regarding procedure and ethics).  
A member of the research team contacted women by telephone one week after the 
information sheet was given. Additional information and reiteration that their participation 
was entirely voluntary was provided. If, at this point, women agreed to participate, a time was 
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arranged to meet, gain written consent (appendix 7) and complete the interview. Recruitment 
of participants was conducted in parallel with analysis, ending when the 12 interviews 
provided consistent findings.   
Semi-structured, face-to-face interviews (20 to 70 minute duration) were conducted at private 
locations that were convenient to participants (home, work, or hospital).  The trainee 
conducted 10 out of the 12 interviews; the Research Assistant who formed part of the 
research team conducted the remaining two. Semi-structured interviews offered the 
opportunity to explore questions relevant to the study whilst allowing participants the 
opportunity to answer freely. In order to characterise the sample, participants completed a 
brief demographic information sheet (appendix 8) and the Hospital Anxiety and Depression 
Scale ([HADS] Zigmond & Snaith, 1983, appendix 9). The HADS was selected due to its 
brevity whilst maintaining good validity (Bjelland, Dahl, Haug,
 
& Neckelmann,
 
2002).  
The interviews followed an interview guide (appendix 10), developed in response to the 
findings of Beesley et al. (2013) and previous literature in the area. Predetermined topics 
included: How women thought and felt before, during and after their decision-making 
regarding RRM and the role of risk perception in this process. Interviews were conversational 
using reflection and open-ended questions to allow participants to talk freely. Focused 
questions were used to gain more specific information and to address the tendency of 
interviewees to give socially appropriate or vague answers to generic questioning (Legard, 
Keegan, & Ward, 2003). Focused questions followed general questions to enable 
interviewees to respond freely to the former. Interviewers took a non-directive, non-
judgmental stance to participants’ responses. A protocol for dealing with distress (appendix 
11) was available, but not required. 
The interview guide was refined in response to the ongoing analysis in order to test and 
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develop the findings (see appendix 10 for refinements). Refinements included the addition of 
several questions asking women to provide a percentage estimate of their level of risk before 
and after RRM. These questions were added to explore whether women’s descriptions of 
‘elimination’ of risk reflected a misunderstanding of the risk-reducing capability of RRM, or 
whether women used such language in spite of recognition that the procedure could not 
eliminate risk. These questions were placed at the end of the interview to avoid influencing 
women’s recall. Participants were given the option of receiving a summary of the results; 
eleven out of twelve chose to receive this information. Interviews were digitally recorded and 
then transcribed by an independent transcription company; the research team checked 
transcripts for accuracy. Field notes and reflections were kept by the interviewer to inform 
the analysis process. All data were stored in line with a data protection protocol (appendix 
12).  
Data Analysis 
The study took a pragmatic approach to qualitative analysis that flexibly applies methods and 
epistemological positions as required by the data and the developing analysis (see appendix 6 
for further details). This approach is similar to that advocated by Gwyn (2002) and enabled 
the researchers to overcome criticism that rigid adherence to specific method restricts the 
creative inquiry process (Barbour, 2001; Chamberlain, 2000; Salmon, 2003; Seale, 1999). By 
drawing on widely used and tested methodology the study was able to maintain creativity 
whilst retaining rigor. This approach to data analysis has previously been used by researchers 
addressing clinical communication data (e.g. Salmon, Mendick, & Young, 2011; Wright, 
Holcombe, & Salmon, 2004). 
Each transcript was read and re-read individually by each member of the research team and 
then presented by the trainee and discussed together in a research meeting. Following each 
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research meeting the trainee used these discussions to form the ongoing analysis, which was 
then taken back to research meetings to be commented on and then discussed in light of new 
data. This was an ongoing process. A brief narrative of the key features of each interview was 
developed to aid remembering and reflection (appendix 13 for example).  
Group analysis allowed consensus validity (Stiles, 1999). Periodic involvement from the 
wider research team was used to test the emerging analysis and increase credibility. Analysis 
paralleled data collection, informing the continued conceptual and procedural evolution of 
the interview guide (Seale, 1999; Stiles, 1993, 1999; Yardley, 2000) allowing testing and 
development of the emerging theory. Disagreements were encouraged and resolved through 
discussion. Dependability of the interpretation was increased by the development of an audit 
trail through meeting summaries (appendix 14, completed by the Research Assistant) and 
ongoing analysis records completed by the trainee (appendix 15 and 16).  
The study followed a constant comparative approach within which the analysis moved 
between descriptive approaches and more interpretative approaches as required by the data. 
The analysis initially drew heavily on thematic analysis allowing identification of recurrent 
features of the participants’ accounts (appendix 15). As the analysis progressed, and as 
required by the data, (e.g. when it was identified that that accounts may serve functions other 
than surface meanings), interpretive analysis and perspectives from sociolinguistic and 
discourse approaches were drawn upon. This allowed the data to be understood within the 
context of the whole interview and the wider analysis, and also within the context of the 
interview setting and wider social context. Pivotal cases, outliers and contradictions to the 
emerging analysis were highlighted and discussed. Conceptual categories (appendix 16) were 
developed as a result of this process and considered in relation to clinical and research utility, 
the catalytic validity and theoretical validity (Kincheloe & McLaren, 2000). Changes to the 
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conceptual categories during analysis were recorded throughout and tested through 
refinements to the interview guide.  
Results 
Sample Characteristics 
Participants ranged in age from 25-65 years, (see table 1 for demographic information by 
participant). Three opted for BRRM and nine for CRRM. Four women had completed the 
surgery before the interview. The women had a diverse educational background, the highest 
being degree level and the lowest being National Vocational Qualification / GCSE. Four 
women had a known BRCA mutation and two were BRCA negative. BRCA status in the 
remaining sample was unknown at the time of the interview. One woman in the sample did 
not have a personal history of breast cancer, seven women had a family history of breast 
cancer and one participant had a family history of cancer other than breast cancer. One 
participant met the HADS cut off for elevated depression (>8) and eight for elevated anxiety 
(>8) (Snaith & Zigmond, 1994).  
Table 1:  
Demographic information 
ID Age 
range 
Type of 
surgery 
Highest  
qualification 
Personal 
BC 
history 
Time since 
Treat 
Cancer 
Time 
since 
Diagnosis 
Family 
BC 
history 
Family 
cancer 
history 
(other 
than BC 
BRCA 
Status 
HADS 
Depressio
n total 
HADS 
anxiety 
score 
ID1 46-50 CRRM Diploma Y 12 
months 
(m)  
25 m N Y  Not taken 0 1 
ID2 35-40 BRRM GCSE N NA NA Y N Not 
possible 
6 10 
ID3 60-65 BRRM O-levels Y 14 m 20 m Y N Positive 1 2 
ID4 25-30 CRRM NVQ Y 6 m 12 m N N Negative 5 8 
ID5 46-50 CRRM A-levels Y 15 m 20 m  Y N Going for 
tests 
4 8 
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ID6 46-50 CRRM GCSE Y 6 m 12 m N N Positive 10 8 
ID7 56-60 CRRM NVQ Y 5 m 12 m Y N Positive 6 10 
ID8 46-50 BRRM GCSE Y 25 m 34 m Y N Positive 4 13 
ID9 46-50 CRRM Degree Y Unavail-
able 
24 m N N Not taken 1 5 
ID10 46-50 CRRM GCSE Y 24 m 84 m N N Not taken 5 8 
ID11 31-35 CRRM A Level Y 6 m 18 m Y N Negative 2 7 
ID12 46-50 CRRM BSc Y 1 m 7 m Y N Not 
possible 
3 11 
 
Summary of Analysis 
Overall, the findings suggested that women’s decision to opt for RRM is primarily driven by 
fear that is characterised by a sense of menace involving beliefs relating to the implacability 
and undetectability of future cancer. Women held beliefs about the need to do everything 
possible to prevent cancer; these beliefs appear to translate the sense of menace into decision-
making. Women then attempted to justify and rationalise the decision, but this seems to have 
little bearing on the decision outcome. Women’s social environments, particularly discussion 
with their friends, family and peers and influence of the media, form an important context in 
which the second and third stages play out (see figure 1).  
 
Figure 1. Diagrammatic representation of decision-making in RRM 
 
  
Fear  
I must do 
everything I can 
Justification 
Social World (friends, 
peers, family, the media) 
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Fear and Menace 
Most women discussed their decision to opt for RRM in relation to fear of breast cancer: R: 
“What do you think was driving that kneejerk (decision to have RRM), do you think?” P: 
“Fear I think. I think it’s a fear factor that, you know…” (participant 9). Women talked about 
this fear being the main driver of their decision: “Yeah.  Just the fear of a comeback again is 
um is, is what… really that’s the main thing really, you know” (participant 7). This fear was 
discussed together with a sense that breast cancer was a menace. 
Menace was heightened by the perception that cancer could lurk undetected in the body: 
“You know, your body can turn bandit at any point, can’t it?” (participant 1). Several women 
believed that screening and early detection technology was incapable of detecting the cancers 
that they were likely to experience. “Yeah, just not being able to ever detect it, that is my 
main worry, that they could literally monitor the other one now for the rest of my life and still 
not find it. Because it has happened, it’s actually... If something that horrible has happened 
to you, you sort of don’t trust the tests anymore.” (participant 5). Women also described 
being unaware of having the disease, often using highly emotive language and metaphor to 
describe their beliefs about the threat of cancer: “You wouldn’t have felt the cancer that you 
had. So, that’s when the brain started ticking thinking so I might have it and not even know 
then, again.  So it’s tormented me for quite a bit” (participant 10). It is however possible to 
see how women’s positioning of the role of fear in their decision-making process may have 
been augmented by their current affect, in particular high levels of anxiety as suggested by 
the scores on the HADS (Zigmond & Snaith, 1983). 
Some women described the likelihood of breast cancer occurrence as a certainty, again using 
emotive language in their description of the threat of breast cancer: “ I just think it’s going to 
come back anyway… I feel like I am just sitting like a little ticking time bomb” (participant 8). 
DECISION-MAKING REGARDING RISK-REDUCING OPTIONS IN BREAST CANCER 
 51 
“It’s that I’m going from this really, almost certain breast cancer to actually [participant 
name], you, you have no reason not to become 53” (participant 12). For these women, the 
decision to opt for RRM appeared to be regarded as a decision between RRM and breast 
cancer. 
Participant 2 was the only contributor who did not have a personal history of breast cancer 
and it seems likely that this influenced the themes elicited. In particular it was noted that for 
her, there was less discussion of fear in relation to breast cancer and it is possible that the role 
of fear in this decision-making process is more central to women who have a personal history 
of breast cancer. Instead, participant two talked about considering the impact that breast 
cancer could have on her children, relating it to her experience of having a mother who had 
the disease. She also described her decision to opt for RRM to be driven by a sense of the 
unknown in relation to whether she had the BRCA gene. Nonetheless, she did allude to her 
decision to opt for RRM as a decision between surgery or breast cancer: “Mum kind of went 
oh, so, oh so you’re actually gonna do it?... Um and, and I just turned to Mum and I said, 
“Well, Mum, what’s the alternative? Go through what you’ve been through, which quite 
frankly looked pretty shit to me.” (participant 2). 
Often women described feeling that numerical risk was irrelevant to their decision. Some 
women highlighted the uniqueness of their case as to why statistics didn't apply: “You know, 
if I’m looking at statistics, the majority of the women are aged 50 or over, and I’m 31. You 
know, those statistics don’t really relate to me as much as they do to other women…” 
(participant 11). Others appeared to simply reject this risk information as irrelevant: R: “if 
she’d have given you a lower number do you think that would have changed your mind?” P: 
“No, 'cause I think I’d made my mind up straightaway” (participant 8). Several women 
described a sense that if risk was present, at any level, then it needed to be acted upon: “Well 
if there was 1% chance that was enough for me” (participant 10). “Even if they’d said it was 
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a 1% risk I probably still would have done it” (participant 11). Five women referred to their 
decision using the phrase ‘no brainer’ seemingly reflecting the lack of cognitive processing 
that they deemed was necessary to make the decision.  
‘I must do everything I can’ 
When reflecting upon their decision to opt for RRM, almost all women referred to a need to 
do all in their power to prevent breast cancer. They saw electing to undergo RRM as a 
consequence of that. Some women expressed anticipatory guilt if breast cancer occurred and 
they felt they had not done everything they could to prevent it: “… if it does come back and I 
didn’t do something about it when I could have done? And it was that, thinking I need to do 
it.” (participant 10).  
Perception of having done ‘all in their power’ allowed women to develop a sense of fatalism 
about developing breast cancer. This sense of fatalism appeared to be emotionally helpful, 
reducing fear and reducing the possibility of regret: “God forbid, if it does come back, well 
that’s something I’ve got to do… deal with then, when it happens, if it happens. So um… but 
it’s still… I, I’d still know in my heart of hearts that I’d done everything I can do, you know” 
(participant 7).  
The centrality of this belief in the decision process is emphasised. Women described it as the 
cause of them choosing RRM. Unlike the justifications (described in the next section), when 
many women reported that considerations would not have made them change their minds, 
women were clear that this belief was a proximal factor in their decision. 
All but two of the women with a personal history of the disease highlighted that they had 
requested RRM at the point of treatment for breast cancer. Women discussed their decision as 
immediate and often framed as ‘get them off’, referring to a woman’s breasts as external and 
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expendable. A number of women referred to their breasts as functional objects that they are 
no longer required: “I’ve had my use of them for 50 odd years; I don’t need them no more 
now. I’ve had my children, so I can get on with it” (participant 3). As highlighted within the 
quote, this theme is likely to be influenced by a woman’s age and life stage, particularly if 
she has, or intends to have, children. Elicitation of this theme may reflect the characteristics 
of the sample included.  
Within the descriptions of needing to do ‘all in their power’, there appears to be a role for the 
social world; namely women’s peers and the media in shaping their decision-making process. 
Women discussed how their peers increased their awareness of the procedure:  “…a lady got 
talking to me in Asda… She said I’ve just been to see my consultant actually to get the other 
one removed. And I was standing there thinking, do you know that’s what I need to do…” 
(participant 1). Several women referred to the media in increasing awareness and 
acceptability: “I don’t know if I’d read something years ago um.. I know it seems to be 
more… people seem to be doing it more nowadays, you know” (participant 7). Through 
increasing availability of information about risk-reducing options and determination of what 
was an acceptable measure to take in order to reduce risk, this social world appeared to shape 
what women perceived to be all they could do.  
Justification 
Women often described a decision-making process, discussing a range of reasons why they 
chose to opt for RRM. However this was often in the context of having identified that the 
decision was made quickly, often requested at the point of treatment for breast cancer and 
primarily driven by fear. Discussion of decision-making as a deliberative process within the 
interview appeared to reflect justification of their decision. This process of justification 
appeared to be emotionally helpful for some women.  
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Participant 9 illustrates this point when discussing her decision to opt for CRRM as a 
‘kneejerk’ driven by fear, and identifying that she had requested RRM at the time of 
treatment for breast cancer. At this point she was told that although RRM was an option but 
that treatment for breast cancer needed to be completed first. She describes that during this 
time she considered additional aspects of her decision: “…during that period, that’s when the 
practical considerations came into it, that actually there’s some practical benefits to this as 
well as psychological benefits.” However, that these practical considerations played no role 
in her decision-making: R: “Do you think if there’d have been sort of negatives practical 
considerations that would have swayed your decision in any way?” P “…No, I don’t think, I 
don’t think if practically it had been more difficult, I think I probably would still have gone 
ahead with it.” She goes on to describe this period as emotionally helpful: “it was an 
unusual… way to make a decision for me, but it was the emotion made the decision, the 
moving it to the practical … just, I think, helped me rationalise it… and helped me make 
myself feel comfortable with an emotional decision… And I’m glad I had that time to do that. 
I think I’m better for having had that time”. Although women who requested RRM at the 
point of treatment could recognise the value of a waiting period between treatment and RRM, 
for many, the outcome of the decision did not change: “and he said ‘Have you made your 
decision?’ and I said ‘Yeah.’  I said, ‘It was made from the first time I asked you but, with 
respect, I knew I had to take that amount of time to, to think about it’ ” (participant 9). 
Participant 9 appeared aware of the temporal elements and role of justification in her 
decision-making. For others, this process of justification seemed to occur but was not 
explicitly stated. Participant 1 talks about the ‘fear’ of finding a lump in her breast and 
discusses her decision as being driven by fear: “The fear is always going to be psychological.  
I think it’s more of a psychological decision that you make” but later talks about the medical 
reasons for her decision: “And that’s another element, being on my right side that, if I found a 
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lump and it had already gone to sentinel lymph nodes, I can’t have my lymph nodes removed 
from my arm.” (participant 1).  
Within the process of justification, women also appeared to draw on their social world, 
particularly their family and friends to justify their decision, often identifying them as 
influential in their decision-making process, but again often in the context of also identifying 
the decision as immediate and personal. Participant 8 illustrates this point. When discussing 
her decision-making process she states: “… so straightaway it was like, no, I want them off 
now. I’m just too terrified of it coming back now.” And later describes the role that her 
children, partner and friends played in her decision-making: “Yeah. I mean I say I think the 
kids are a big influence to me…because they’re the ones like, mum you’ve got to give it a 
chance, you know what I mean, you’re talking about your life here.”  R: “was there anyone 
else that you think played a part in your decision-making at the time?” P: “Probably my 
partner as well… R... So did you, did you discuss your decision with your partner? P: “Yeah, 
even, even to him it was a no-brainer. You know, so what, you’ve got to get it done.” When 
talking about her friends she says: “But I think they influenced me as well, 'cause they’re all 
like, you know, if it was me I’d just have them, be gone with them”. The involvement of her 
family and friends in her decision appeared to have occurred after she had made her decision. 
Several women emphasised in the interview that their social world more widely agreed with 
them: “There is absolutely nobody who disagrees with me, even, um, when I spoke to (name 
omitted) even she was like, “Oh god”, you know. I think everyone's reaction is like, every 
single person, well female you know, that I have spoken to has gone I would do exactly the 
same.” (participant 5). 
 
 
DECISION-MAKING REGARDING RISK-REDUCING OPTIONS IN BREAST CANCER 
 56 
Discussion 
This study used qualitative methods to explore women’s decision-making around RRM, 
particularly the relevance of risk perception and emotion in this process. From analysis of the 
12 semi-structured interviews it was suggested that women made their decision to opt for 
RRM primarily based on a sense of fear, characterised by a sense of menace and the need to 
do all in their power to reduce their risk. Women then appeared to go through a process of 
justifying their decision, where the outcome of the decision did not change. 
The origins of women’s decision-making appear to be the sense of menace that they 
described. This sense was described in both cognitive (unpredictability and undetectability) 
and emotional (fear) terms, with the boundaries between the two being unclear. Women were 
clear that the fear component was important in their decision-making. The nature of this 
emotional driver appears to differ from the sense of vulnerability that Beesley et al. (2013) 
reported. The sense of menace was visceral, possibly because cancer was seen as originating 
within the self and was undetectable. Thus, women felt unable to predict or control the threat. 
This fear seemed linked to their personal experience of breast cancer, which represented a 
standard by which to assess risk (Grenning, Dollinger, & Pitz, 1996).  
Women also described an imperative to ‘do all I can’ to prevent reoccurrence. This 
imperative was important in driving their decision. Indeed, few women reported considering 
risks of the procedure or indeed the magnitude of risk reduction that could be achieved by 
RRM. A review of the qualitative literature failed to find a similar construct, suggesting that 
this belief may be restricted to the context of RRM choice in women who have experienced 
cancer, but a lack of women in the sample who did not have a personal history of the disease 
makes conclusions difficult. We speculate that this imperative arises from the intense sense 
of menace that women felt and their need to act to curtail the threat. This led to a form of 
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anticipatory guilt (van Dijk, van Roosmalen, Otten, & Stalmeier, 2008) whereby women felt 
obliged to act to reduce risk. 
Women did describe a number of other considerations, such as asking the views of family 
and clinical staff and considering the pros and cons of the procedure. These are considered 
justifications because they were not reported as proximal to the decision itself and several 
women reported that these considerations would not necessarily have made them change their 
minds. There are two possible functions of justification; they may exist to convince women 
that they have made sensible and consensual decisions, or they may provide a form of 
decisional support enabling women to feel more confident in moving toward surgery.  
If these are justifications, this appears to contradict research that suggests that women use 
others to assist with their decision-making process (Howard, Balneaves, Bottorff, & Rodney, 
2011). DeVries, Fagerlin, Witteman and Schere (2012) suggest that mental effort is often 
perceived as a signal that a ‘good’ decision has been made because people believe that metal 
effort is necessary for effective decision-making and creates a sense of acceptance with the 
decision outcome.  
Relationship to Theory  
The finding that decisions to opt for RRM were driven by a sense of menace characterised by 
high levels of fear contradicts utility theories such as the Health Belief Theory (Hochbaum, 
1958) and Protection Motivation Theory (Rogers, 1975, 1983), which propose that people 
make decisions based on deliberative processing of severity and likelihood of harm. 
Women’s denial of the value of statistics and reflection of their decision-making as lacking 
cognitive reasoning also appears to call into question the role of deliberative processing 
proposed by dual-processing models. Where deliberative processing was reported it seemed 
to reflect a process of justification, rather than an integral factor to decision outcome. The 
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role of emotion appears to play a more central role than that predicted by dual-process 
models.  
The sense of menace described and the suggested relevance of personal experience of breast 
cancer in creating this sense of menace appear to support Fuzzy Trace Theory ([FTT] Reyna 
and Adam, 2003). FTT proposes that risk is encoded and represented in terms of general 
meanings (FTT uses the term ‘gist’) that people abstract from their experiences rather than 
detailed verbatim representations of reality (e.g., specific risk likelihood estimates). Gists are 
idiographic and contain both cognitive and emotional components, which, unlike dual 
process theories, are not seen as separable. FTT suggests that meaning (gist) is actively 
constructed from experience, the context in which risk-related information is obtained and 
opportunities to consider and process this information (Reyna, 2004). 
Strengths and Limitations  
The study limited the sample to women at increased risk of breast cancer who had chosen to 
opt for RRM. Beyond this however, the inclusion criteria were deliberatively broad allowing 
the population of women choosing RRM at the breast unit to be represented. The 
heterogeneity in the sample that resulted from these broad inclusion criteria made it possible 
to identify potential influences on women’s descriptions of their decision-making process by 
analysing decision processes in women with different experiences. This was particularly 
valuable because insight provided from the inclusion of one woman who had a personal 
history of breast cancer provided some contradictions to the wider analysis. This suggests 
that a personal history of breast cancer influences decision-making. However the ability of 
the study to explore this issue is limited; inclusion of more women without a personal cancer 
history would have provided opportunities to consolidate and refine this finding. Additionally, 
the study describes decision-making in women who opted for RRM, it would be valuable to 
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contrast this to women who were eligible but opted against RRM. A purposive sampling 
technique would allow these sampling difficulties to be addressed.  
The use of a qualitative methodology allowed the study to gain a rich description of women’s 
personal experiences of decision-making in this area, addressing a gap in current evidence. 
However, as with all qualitative research, the study is limited to the information that 
participants are willing and able to share with the researcher; aspects of the decision-making 
process which are implicit or otherwise concealed from participants’ insights cannot be 
explored (Knox & Burkard, 2009).  
Drawing on widely used and tested methodology through a pragmatic approach to data 
analysis, the study was able to respond sensitively to the data, whilst retaining rigor. However, 
unlike more widely used qualitative approaches, the approach adopted lacks predetermined 
guidelines for implementation that ensure standardised process (Pistrang & Barker, 2012). 
However, through group analysis, periodic involvement from the wider research team and 
detailed analysis note keeping, validity and credibility of the findings was enhanced. 
Additionally, through consideration of the emerging findings in relation to clinical and 
research utility, the study was able to increase catalytic validity and theoretical validity 
(Kincheloe & McLaren, 2000). 
Practical Implications 
The findings describe the decision to opt for RRM to be largely driven by a sense of menace 
in the absence of deliberative consideration of the risk-reducing potential of the procedure or 
possible side effects. This finding builds on the work of Beesley et al. (2013), showing a 
tension between accepting autonomous patient decision-making that may not be based on 
considered thought and utilitarian models of decision-making, which promote rational 
deliberation of risk. 
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There are several options for intervention. First is to try to change women’s decision-making 
processes to fit with utilitarian principles. This may involve decisions aids, which aim to 
promote deliberative decision-making (De Vries et al., 2013). However, it may be difficult to 
achieve this, and there is some evidence that intuitive or emotion-based decision-making can 
actually lead to better decisions (De Vires et al., 2013). A further option may be to attempt to 
reduce the fear and worry described by women as central to their decision-making process, 
for example through the provision of psychological therapies. From the data, it seems likely 
that a therapeutic modality that aims to address the process as opposed to the content of fear 
and worry, for example metacognitive therapy (Wells & Matthews, 1994), may be useful. 
However, again it has been argued that affect is an essential component of effective decision-
making (De Vires, et al., 2013). Finally, it may be possible to offer an argument that 
decision-making that draws heavily on affect is a valid decision-making style, with reduction 
in negative affect, a valid reason for undertaking RRM. Thus, it seems important to 
understand the advantages and disadvantages of the ways in which women make RRM 
decisions. 
Conclusions 
The findings suggest that women’s decisions to opt for RRM was driven by a sense of 
menace, which was characterised by high levels of fear. This menace was translated into 
action by a belief that they must do all they could to reduce risk. The role of deliberative 
decision-making occurred later as a process of justification, which did not impact upon 
decision outcome. Given this understanding, it would now be useful to go further to 
understand the value of this decision-making style and its implications for decision-making 
support.  
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Appendix 1: Author guidelines: Health Psychology Review 
Manuscripts are accepted in English. British English spelling and punctuation are preferred. 
Taylor & Francis Standard Reference Style: APA 6th Edition 
Articles to Health Psychology Review should therefore be no longer than 30 double-spaced 
manuscript pages. Manuscripts should be compiled in the following order: title page; 
abstract; keywords; main text; acknowledgements; references; appendices (as appropriate); 
table(s) with caption(s) (on individual pages); figure caption(s) (as a list). Abstracts of 200 
words are required for all manuscripts submitted. 
Each manuscript should have 3 to 6 keywords. 
In order to comply with international standards and for academic transparency, authors of 
meta-analyses and systematic reviews submitted to Health Psychology Review are required to 
include a statement in accordance with the Preferred Reporting Items for Systematic Reviews 
and Meta-Analyses (PRISMA) statement (http://www.prisma-statement.org/ ). 
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Appendix 2: Scoping searches / Process Notes 
Search Strategy 1 
“Breast Cancer” OR “Breast neoplasm” OR “Breast Carcinoma” AND “increased risk” OR 
“elevated risk” OR “high risk” OR “moderate risk” OR brca*1 OR brca*2 OR tp53 OR 
“genetic risk” OR “hereditary risk” OR inherit* OR familial OR Ashkenazi AND “Risk 
perception” OR “Risk understanding” OR “Perceived risk” OR Worry OR Dread OR 
“Anticipated emotion” OR “Anticipatory emotion” OR Affect OR Emotion* OR 
Vulnerability AND increased risk OR “elevated risk” OR “high risk” OR “moderate risk” OR 
brca*1 OR brca*2 OR tp53 OR genetic risk OR hereditary risk OR inherit* OR familial OR 
Ashkenazi 
Reflection: Specific to increased risk = too restrictive (search by hand?) 
Search Strategy 2 
“Breast Cancer” OR “Breast neoplasm” OR “Breast Carcinoma” AND “increased risk” OR 
“elevated risk” OR “high risk” OR “moderate risk” OR brca*1 OR brca*2 OR tp53 OR 
“genetic risk” OR “hereditary risk” OR inherit* OR familial OR Ashkenazi AND “Risk 
perception” OR “Risk understanding” OR “Perceived risk” OR Worry OR Dread OR 
“Anticipated emotion” OR “Anticipatory emotion” OR Affect OR Emotion* OR 
Vulnerability 
Reflection: Papers not particularly relevant. Search qualitative papers only. 
Final Search Strategy 
1- “breast cancer” OR “breast carcinoma” OR “breast neoplasm” 
AND  
2- “risk perception” OR “risk understanding” OR “perceived risk” OR worry OR 
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dread OR “anticipated emotion” OR “anticipatory emotion” OR affect OR 
emotion* OR vulnerability  
AND 
Qualitative OR “Grounded theory” OR IPA OR “Interpretative Phenomenological 
Analysis” OR “Thematic analysis” OR “Content analysis” OR “Narrative analysis” OR 
“Conversation analysis” OR “Narrative analysis” OR “Discourse analysis” OR 
Interview* OR Observation OR “Focus groups” 
Table 1:  
Example of full search and record of number of results per search term (Psych INFO) 
Word Hits 
“Breast Cancer” 7781 
“Breast Carcinoma” 70 
“Breast neoplasm” 4 
“Breast Cancer” OR “Breast neoplasm” OR “Breast 
Carcinoma” 
7818 
“Risk perception” 5209 
“Risk understanding” 37 
“Perceived risk” 2237 
Worry 7789 
Dread 778 
“Anticipated emotion” 21 
“Anticipatory emotion” 1 
Affect 157393 
Emotion* 285272 
Vulnerability  
 
24474 
“Risk perception” OR “Risk understanding” OR “Perceived 
risk” OR Worry OR Dread OR “Anticipated emotion” OR 
“Anticipatory emotion” OR Affect OR Emotion* OR 
Vulnerability  
442486 
Qualitative 87,429 
“Grounded theory” 8,638 
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IPA 943 
“Interpretative Phenomenological Analysis” 786 
“Thematic analysis” 3252 
“Content analysis” 15,003 
“Narrative analysis” 1264 
“Conversation analysis” 1163 
“Narrative analysis” 1264 
“Discourse analysis” 7763 
Interview* 208514 
Observation 101276 
“Focus groups” 10921 
Qualitative OR “Grounded theory” OR IPA OR 
“Interpretative Phenomenological Analysis” OR “Thematic 
analysis” OR “Content analysis” OR “Narrative analysis” OR 
“Conversation analysis” OR “Narrative analysis” OR 
“Discourse analysis” OR Interview* OR Observation OR 
“Focus groups” 
360788 
“Breast Cancer” OR “Breast neoplasm” OR “Breast 
Carcinoma” AND “Risk perception” OR “Risk 
understanding” OR “Perceived risk” OR Worry OR Dread 
OR “Anticipated emotion” OR “Anticipatory emotion” OR 
Affect OR Emotion* OR Vulnerability AND Qualitative OR 
“Grounded theory” OR IPA OR “Interpretative 
Phenomenological Analysis” OR “Thematic analysis” OR 
“Content analysis” OR “Narrative analysis” OR 
“Conversation analysis” OR “Narrative analysis” OR 
“Discourse analysis” OR Interview* OR Observation OR 
“Focus groups”   
522 
“Breast Cancer” OR “Breast neoplasm” OR “Breast 
Carcinoma” AND “Risk perception” OR “Risk 
understanding” OR “Perceived risk” OR Worry OR Dread 
OR “Anticipated emotion” OR “Anticipatory emotion” OR 
Emotion* OR Vulnerability AND Qualitative OR “Grounded 
theory” OR IPA OR “Interpretative Phenomenological 
Analysis” OR “Thematic analysis” OR “Content analysis” 
OR “Narrative analysis” OR “Conversation analysis” OR 
“Discourse analysis” OR Interview* OR “Focus groups”   
443 
 
417 English 
Note. Database searched PschINFO; date searched 11/10/2013; terms searched article, title, 
abstract, keyword (any field) 
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Table 2: 
Total combined search by database 
Database Results 
PsychINFO 417 
Scopus 666 
Web of Knowledge 1026 
Medline 555 
Hand Searching 15 
Total 2679 
 
Table 3: 
Number of studies exlcuded at each point 
Point of exclusion Total removed Total remaining 
Duplicates 1351 1328 
Title 284 1044 
Abstract 922 122 
Full text  108 16 
 
Table 4:  
Exclusion from title 
Reason  Number  
Sample 282 
Methodology 1 
Type 1 
 
Table 5:  
Exclusion from abstract 
Reason  Number 
Sample 380 
Topic 323 
Methodology 183 
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Type 27 
Duplicates not previously identified 9 
 
Table 6: 
Exclusion from full text 
Reason  Number 
Sample 31 
Topic 47 
Methodology 6 
Type 12 
Duplicates not previously identified 2 
Unable to access 8 
 
Table 7: 
Reasons for exclusion  
Main Reason Examples 
Sample Carer  
Child  
Current BC 
Male 
Not Breast cancer/ not only BC 
Professional sample 
Not increased risk/ population  
Method Quantitative 
Single case study 
Forced choice interview 
RP as % 
Type Review 
Dissertation  
Critique of a book 
Poster 
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Book 
Editorial/ position paper 
Topic Not womens’ experience 
Not specific to BC 
Not investigating women’s risk perception  
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Appendix 3 CASP Assessment Tool 
Table 1:  
Quality rating using CASP tool 
 Altschuler 
& Somkin 
(2005) 
Beesley, 
Holcombe, 
Brown & 
Salmon 
(2013) 
Bennett, 
Parsons, 
Brain, & 
Hood 
(2010) 
Chalmers, & 
Thomson 
(1996) 
Dagan, & 
Goldblatt, 
(2009) 
Hallowell, 
Foster, Eeles, 
Ardern-Jones, 
& Watson 
(2004) 
Hoskins, 
Roy, & 
Greene 
(2012) 
Kelly 
(1980) 
Kenen, 
Ardern-
Jones, & 
Eeles 
(2003) 
Keogh, 
McClare
n, 
Apicella 
& 
Hopper 
(2011) 
Raveis 
& 
Pretter 
(2005) 
Roberts
on 
(2000) 
 
Sheinfel
d Gorin, 
Albert 
(2003) 
Werne
r- Lin 
(2007) 
Was there a clear statement of 
the aims of the research? 
 
Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Is a qualitative methodology 
appropriate? 
Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Was the research design 
appropriate to 
address the aims of the research? 
 
Y Y N N Y Y Y Y Y Y Y N Y Y 
Was the recruitment strategy 
appropriate to the aims of the 
research? 
Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
Was the data collected in a way 
that addressed the research 
issue? 
 
Y N/A Y Y Y Y Y N Y Y Y Y N Y 
Has the relationship between 
researcher and participants been 
adequately considered? 
 
N N N N Y N Y Y Y N N N N N 
Have ethical issues been taken 
into consideration? 
N Y Y Y Y Y Y N Y Y Y N Y N 
Was the data analysis 
sufficiently rigorous? 
Y Y N Y Y Y Y N N Y Y N Y Y 
Is there a clear statement of 
findings? 
Y Y Y Y Y Y Y Y Y Y Y Y Y Y 
How valuable is the research? Valuable Valuable Valuable Valuable Valuable Valuable Valuabl
e 
Valuabl
e 
Valuabl
e 
Valuabl
e 
Valuab
le  
Valuab
le 
Valuab
le 
Valua
ble 
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Appendix 4: Author Guidelines 
Empirical: Journal of Psychology and Health 
Aims and Scope: Psychology & Health promotes the study and application of psychological 
approaches to health and illness. The contents include work on psychological aspects of 
physical illness, treatment processes and recovery; psychosocial factors in the aetiology of 
physical illnesses; health attitudes and behaviour, including prevention; the individual-health 
care system interface particularly communication and psychologically-based interventions. 
The journal publishes original research, and accepts not only papers describing rigorous 
empirical work, including meta-analyses, but also those outlining new psychological 
approaches and interventions in health-related fields.  
Manuscripts are accepted in English. British English spelling and punctuation are preferred.  
A typical manuscript will not exceed 30 pages including tables, references, captions and 
endnotes. Manuscripts that greatly exceed this will be critically reviewed with respect to 
length. Authors should include a word count with their manuscript. 
Manuscripts should be compiled in the following order: title page; abstract; keywords; main 
text; acknowledgements; references; appendices (as appropriate); table(s) with caption(s) (on 
individual pages); figure caption(s) (as a list). 
Abstracts of 200 words are required for all manuscripts submitted.  
Each manuscript should have 3 to 6 keywords.  
Taylor & Francis Standard Reference Style: APA 6
th
 Edition 
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Appendix 5: Participant information sheet 
 
 
 
 
 
 
 
 
Patient Information Sheet 
 
Patient and surgeon decision-making in risk-reducing mastectomy: an 
ethical and empirical analysis 
1  
 
 
You are being invited to take part in a research study.  Before you decide to 
take part or not, it is important for you to understand why the research is being 
done and what it will involve.  Please take time to read the following 
information carefully and discuss it with others if you wish.  Ask us if there is 
anything that is not clear, or if you would like more information.  Take time to 
decide whether or not you wish to take part. 
 
Thank you for reading this. 
Trust Information Removed 
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What is the purpose of the study? 
 
We are interested to learn how women make decisions about whether to have a risk-reducing 
mastectomy or not. We are also interested in how clinical staff help them to make their 
decisions and how they see their role in the decision process. We hope that our findings will 
help us to understand how clinicians can best help women to make decisions in future.  
 
Why have I been chosen? 
 
You have been asked to take part in the study because we understand that you have 
considered having a risk-reducing mastectomy (Breast Unit name) at (location). 
  
Do I have to take part? 
 
You do not have to take part in this study.  It is up to you to decide whether or not to take part.  
If you decide to take part, you will be given this Information Sheet to keep and will be asked to 
sign a consent form.  If you decide to take part you are still free to withdraw at any time and 
without giving a reason.  Whether you participate or not will not affect the care you receive. If 
you were to participate but then withdraw, this would not affect the care you receive either. 
 
What will happen to me if I take part? 
 
If you choose to take part, you will be given a copy of this Information Sheet and a signed 
Consent Form to keep. 
 
We would like to interview you about how you have thought about the possibility of having this 
operation and how you decided about it. In particular, we are interested in how you thought and 
felt about the risk of cancer and risk-reducing mastectomy and how you and your clinician came 
to decide about what is best to do. You can choose whether you would prefer to be interviewed 
at the (Breast Unit) at the University of Liverpool or at your own home.  If you choose to be 
interviewed at the Breast Unit name or the University of Liverpool, your travel expenses will be 
paid.   
 
 Your interview will be audio-recorded if you agree to this.  The length of the interview will vary, 
depending on how much you wish to talk about.  However, the interview is likely to last between 
20 minutes and 60 minutes.   
 
 The audio-recordings of the interview will be typed up by the researcher.  All information which 
might identify you will be removed and replaced by a code so that any personal information 
(such as names, addresses, doctors’ names etc.) will not be included in the research.   
 
 The interview will focus on the following topics: how you viewed the risk of breast cancer 
(re)occurrence, how you first became aware of the possibility of having a risk-reducing 
mastectomy, the factors that contributed to your preferences to have the risk-reducing 
mastectomy or not and how you and the clinical staff interacted to make the decision.  
 
 With your permission, we would also like to interview clinical staff who have been involved in 
this decision.  None of the interviewees will be told what any other interviewee has told us. 
 
What are the possible disadvantages of taking part? 
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The interview may involve talking about information that was or is upsetting for you. However, 
you do not have to talk about anything you do not wish to.  If you feel that you need help with 
any of the matters that we have discussed one of the research team will be happy to speak to 
you to give you advice on further sources of support.   
 
What are the possible benefits of taking part? 
 
You will not personally benefit from taking part in the study.  However, any information that you 
give us can help us find out more about how people make this decision and about the roles that 
clinical staff should play.  We hope that our findings will help clinicians to be more effective in 
helping women in future. 
 
What if something goes wrong? 
 
If you wish to complain, or have any concerns about any aspect of the way you have been 
approached or treated during the course of this study, the normal National Health Service 
complaints mechanisms will be available to you. You can complain to: 
 
Customer Relations Team 
(name) 
Address 
Email 
 
(name) Hospital Patient Quality team (contact number) 
 
Will my taking part in this study be kept confidential? 
 
All data collected for this study will be kept safely and securely on computer and on transcribed 
paper records. (Chief investigator name) will be the custodian of all study data.  All information 
about you will be confidential.  Any information which identifies you (for example, your name, 
names of family, friends, and doctors, addresses, names of hospitals, telephone numbers, date 
of birth, and employment) will be removed from transcriptions and replaced by a code.    
 
What will happen when the study ends? 
 
After all identifying details have been removed from the transcribed records of consultations 
and interviews, these will be analysed by the study team. The results will be published in 
reports and scientific journals, but it will not be possible to identify any individuals from these 
reports.  Any quotation used in the writing up of the final study will be kept anonymous.    
 
With your permission, transcripts of audio recordings of interviews and consultations will be 
stored at the University of Liverpool for 10 years after the end of this study for possible use in 
future studies. If you consent to it, a printed transcript of the interview will be offered to UK Data 
Archive where it will be made available to future researchers. All information that might enable 
you to be recognised will be removed from these records 
 
What will happen to the results of the research study? 
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The clinical psychology student who is part of the team will write up the results of the study for 
for the Degree of Doctor of Clinical Psychology.  This thesis will be kept in the library of the 
Division of Clinical Psychology, University of Liverpool.  A copy of this thesis will also be kept in 
the University’s Library.  After the interview, you can ask if you would like a summary of these 
results, which will then be available after October 2014.  You will not be identified in these 
results. 
 
We will also write the results up to publish them in academic journals.  After the interview, you 
can also ask if you would like a copy of these publications.  You will not be identified in any 
publications. 
 
Who is organizing and funding the research? 
 
The chief investigator is (name), a senior lecturer at Liverpool University. He is collaborating 
with (names). (name) is employed as a Research Officer to conduct the research, and (name) 
is a student in Clinical Psychology who is conducting the research as part of her qualification. 
 
The Economic and Social Research Council is funding the research. 
 
 
Who has reviewed the study? 
 
The study has been reviewed by: 
 The Department of Psychological Sciences at Liverpool University 
 The Economic and Social Research Committee 
 (name) Local Research Ethics Committee. 
 
 
Contact information 
 
(name) Chief investigator 
Contact address 
 
Tel: (contact number) 
Email: (contact email) 
 
For independent advice please contact: 
Patient Advice and Liaison Service 
Contact 
 
Contact 
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Appendix 6: Further Study Details 
Location within the Wider Study 
This research was part of a wider study titled: Patient and surgeon decision-making in risk-
reducing mastectomy: An ethical and empirical analysis, conducted by staff at the University 
of Liverpool.  The larger study aimed to investigate and triangulate patient and surgeon 
decision-making and draw conclusions regarding the quality of decision-making. This 
research aimed to specifically explore women’s decision-making with particular focus on the 
role of risk perception and emotion and the links with current theory and practice. The trainee 
was involved in the initial design of the study and reviewed the ethics application, participant 
information sheets and the interview guide. The trainee was involved in all aspects of data 
collection and analysis. Analysis was completed within the team; analysis of the aspects 
relevant to this study was led by the trainee. Data presented within this study will inform the 
analysis of the wider study (alongside data provided from surgeon interviews).  
Procedure and Ethics 
An overview of the procedure and ethics is provided in the main text, additional information 
is offered to allow a more detailed assessment of quality. The wider study received approval 
by the local NHS Research Ethics committee (13/NW/0421) and sponsorship from University 
of Liverpool (UoL000957). Approval was received for the trainee to be involved in the study. 
Details of the trainee and supervisors’ previous research and academic experience were 
provided to evidence that the researchers were competent to complete the study.  
Acknowledgement that interviewing could influence decision-making and the ethical 
difficulties associated with this, resulted in restriction of inclusion to women who did not 
plan to revisit their decision for the three months subsequent to the interview. Recognition of 
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the possible effect of length of time since surgery on recall of the decision-making process 
resulted in exclusion of women over 3 months post-surgery.  
Consent to retain identifying information for the duration of the study was obtained, 
preventing women who had previously participated being approached again and enabling the 
provision of feedback of the results if requested. Identifying details of women who had 
declined participation were not collected as consent to do so had not been provided. Clinical 
staff were asked not to approach women who they knew to have previously declined to 
participate. 
To ensure adequate time to consider participation, potential participants were contacted one 
week after provision of the information sheet. The participant information sheet contained all 
relevant ethical information and this information was verbally reiterated prior to written 
consent being obtained and completion of the interview. All participant information (verbal 
and written) was provided in easily accessible, everyday language.   
Participants were informed that all information would be anonymous unless there was 
concern for their safety or the safety of others (see dealing with distress policy, appendix 11). 
There were no cases that necessitated anonymity to be broken.  Participants were informed 
that their case would be discussed with clinical care staff (for the purpose of the wider study), 
but that information provided during the course of the interview would not be discussed, 
unless anonymously. Women were assured that completion of the study was entirely 
voluntary and would not impact on their care. Participants were informed of their right to 
withdraw or remove their data at any point without negative consequence. One participant 
chose to remove a section of the data she had provided. Following the interview participants 
were afforded the opportunity to ask question and their attention was drawn to the contact 
details for the study on the information sheet. Interviews were conducted at a location 
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convenient for participants (home, hospital, work). In order to maximise the safety of the 
researchers University lone working policy was adhered to.  
Management of data was detailed in a data protection protocol (appendix 12), created prior to 
the start of data collection. Data were recorded on a digital recorder and transferred to a 
secure computer file store and removed from the recorder at the earliest opportunity. An 
independent transcription company, who were required to sign a confidentiality agreement, 
transcribed all audio recordings. Following consistency checks and removal of any potential 
identifying information, audio recordings were deleted. Anonymised transcripts were emailed 
to the core research team for analysis. Participants were informed that the University of 
Liverpool would store an anonymised transcript of the interview for up to ten years, after 
which it would be destroyed. The data custodian (principle investigator) was responsible for 
ensuring that data were destroyed after the adequate time period. Anonymised demographic 
information was kept and linked to interviews by a participant identification number. Signed 
consent forms were kept for the duration of the study. All digital information was stored on 
University computers within a secure file store that only the core research team had access to. 
All identifying written information was stored in a locked cabinet on university premises and 
will be destroyed following completion of the wider study.  
Epistemology and Methodology 
The research questions posed necessitated a qualitative approach. As detailed, the research 
took a pragmatic approach to data analysis similar to that advocated by Gwyn (2002), 
allowing a range of methodologies and epistemological positions to be drawn upon as 
required by the data, examples of which are provided. The use of pluralist qualitative 
research is increasing and guidance is now available about how to conduct such research in a 
rigorous and valid way (e.g. Frost, 2011).  
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The research initially attempted to understand how women made decisions regarding RRM 
by how they attempted to convey understanding of their internal world (and decision-making 
process) directly through the language that they used, a largely positivist frame. Use of 
thematic analysis (from a largely positivist position) allowed recognition of recurrent features 
of women’s accounts, for example frequent use of the term ‘fear’ in relation to breast cancer 
occurrence and informed the findings in which fear was hypothesised to drive decision-
making.  
However, the role of context in which these discussions were framed, was also recognised, an 
interpretative social constructionist position. Despite recognition that women conveyed 
meaning through the language they used, the interviews were not regarded as always 
providing direct access to participants’ experiences and intentions, but were interpreted 
within the interview and wider social context. Understanding at the level of individual 
sections of text was combined with awareness and discussion of the whole interview and 
field notes, particularly when there were contradictions in the narrative and times when the 
content appeared to reflect justification rather than explanation. Drawing on discourse 
analysis, women’s emotive language such as frequent reference to others agreeing with their 
decision was hypothesised as women justifying their decision to opt for RRM (to the self and 
the interviewer), possibly due to a negative discourse around mastectomy. This also allowed 
the contradiction in the narratives to be recognised. For example, women would often 
identify the decision to be personal and driven by fear and then identify the role of others in 
the decision-making. This understanding allowed recognition of the role of ‘justification’ in 
the model, an understanding that may not have been reached within a purely positivist frame. 
The potential for pre-decisional processes to be mis-remembered and reconstructed in the 
light of the decisions or ‘altered’ to fit a preferred interpretation (Yardley, 2000) was also 
reflected on and discussed throughout the analysis process.  
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Support for the value of the analysis used comes from a number of published studies 
conducted by members of the research team (e.g. Salmon, Mendick, & Young, 2011; Wright, 
Holcombe, & Salmon, 2004). Experience and expertise within the core research team were 
drawn upon throughout the analysis process to ensure that this procedure was rigorous and 
done in a way that ensured validity.  
Reflexivity 
Reflexivity is important in research; perhaps even more so in pluralist qualitative research 
(Frost, 2011). The researcher had little experience with breast cancer prior to completing the 
research. However, it is possible that the fact that the researcher was a woman may have 
impacted upon the information participants provided and also how it was interpreted. It is 
possible that the researchers consideration of herself in the position of the participants and the 
actions she feel she may take may have influenced how she interacted with the participants 
and the interpretation. 
It was considered whether participants placed the researcher in a position of a ‘health 
professional’ (despite description of the role of the researcher). Evidence for this comes from 
one participant asked questions about her health care. It is possible that being placed in this 
position may have influenced the information that the women provided. It is possible that 
women felt the need to justify their decision and highlight it as rationale more so than if they 
regarded the researcher as independent. Further, one woman talked about feeling ‘grateful to 
the NHS’, it is useful to consider whether this would be the case if the researcher was viewed 
as completely independent.  
Awareness of these potential influences alongside group analysis and discussion was helpful 
in addressing personal biases and influences.  
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Quality and Validity 
The way in which the validity of qualitative research is judged is a contentious topic, with 
some suggesting that qualitative research can be assessed in a way similar to quantitative, 
albeit with related but different concepts, leading to the development of a number of 
checklists to assist been with the assessment of quality (CASP, 2013). However, some 
suggest that the expectation that validity can be assessed in much the same way as 
quantitative methods is ‘absurd’ and others are critical of the use of ‘technical fixes’, 
suggesting that the use of techniques such as triangulation and multiple coding does not in 
itself confer rigour (Barbour, 2001; Salmon, 2003). In an effort to address these criticisms, a 
detailed account of all aspects of data collection and analysis is provided (in the main text 
and above) in order to permit others to judge quality (Patton, 1999), alongside a further 
discussion of various aspects pertaining to quality and validity.   
Dependability 
In an effort to make the research transparent and dependable, detailed records of data analysis 
meetings and discussion relevant to the research project were kept, provide an audit trail that 
is available for review if required. Documents at various stages of refinement (e.g. analysis 
documents and interview schedules) are also available and examples of each have been 
provided. Discussion of other aspects of research quality (e.g. credibility, confirmability) also 
increase the dependability of the findings.  
Credibility 
Transcripts were initially coded by each member of the core research team (multiple coding) 
and brought together at an analysis meeting.  Disagreements were encouraged, discussed and 
explored allowing alternative explanations to be fully explored and analysis to be refined. 
DECISION-MAKING REGARDING RISK-REDUCING OPTIONS IN BREAST CANCER 
 88 
Further confirmation was sought from members of the wider research team (peer review) 
made up of various health professional positions (psychologist, surgeon, nurse). Regular 
discussion of how analysis fit with and contradicted existing theory (triangulation) also 
supported credibility of the findings (Huberman & Miles, 1994). Credibility is further 
ensured through provision of detailed description of findings and detailed quotes. 
Generalisability  
Attempts to characterise the sample through demographic and psychometric (HADS) 
information, alongside description of study participants and setting allows an evaluation of 
the transferability of findings to other settings. Discussion of the context in which the 
findings were positioned (see analysis section above) provides further information relevant to 
assessing generalisability.  
Bias 
Throughout the research process, there was explicit recognition by members of the research 
team about the position of the research following on from Beesley, Holcombe, Brown and 
Salmon (2013) and the potential for the research to pursue these initial conclusions 
(Silverman, 2000).  This awareness and continuous efforts to falsify the emerging analysis 
provided a safeguard against this.   
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Appendix 7: Participant Consent form 
 
 
 
 
 
 
 
 
Centre Number: 
Participant Identification Number for this study:  
 
 
Patient Consent Form  
 
Title of Project: 
Patient and surgeon decision-making in risk-reducing mastectomy: an ethical 
and empirical analysis 
 
Name of researcher: ______________ 
                            Please initial box 
1. I confirm that I have read and understand the information sheet dated ……….. 
(version …….) for the above study. I have had the opportunity of consider the 
information, ask questions and have these answered satisfactorily.  
 
 
2. I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my medical care or legal rights 
being affected. 
  
 
3. I understand that audio recordings will be made as part of this study, and that 
brief quotations from some interviews or consultations may be included in 
study reports. I understand nobody will be able to identify me in these reports. 
   
 
4. I agree to anonymous records of my interview being stored at the University of 
Liverpool for up to 10 years after the end of this study.   
 
Yes No 
5. I agree to one or more staff who have participated in my decision being 
interviewed. I understand that no details of what I have said will be made 
known to them.  
 
Yes No 
6. I agree to an anonymous transcript of my interview being held by the UK Data 
Archive and this being available to other researchers registered with UK Data 
Archive. 
 
Yes No 
7. I would like to receive a summary of the findings at the end of the study.  
 
 
Yes No 
8. I agree to take part in the above study.  
 
 
 
     
Trust Information Removed 
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Name of participant 
 
 
 
 Date  Signature 
Name of researcher   Date    Signature 
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Appendix 8: Demographic information collection sheet 
 
 
Risk-reducing  Mastectomy Study:  Demographics  Form 
 
 
Participant ID:  
 
 
 
Age (please tick): 
 
 
16-20    21-25    26-30    31-35    36-40     
41-45    46-50    51-55    56-60    61-65     
66-70    70+  
 
Education (please tick 
highest qualification):  
 
 
GCSEs or equivalent  
NVQ  
A-Levels or equivalent  
Bachelor’s degree  
Post-graduate degree  
 
Employment status 
(please tick): 
 
 
Unemployed  
Long-term sick  
Part-time  
Full-time  
 
Previous breast cancer 
(please tick): 
 
Yes  
No  
Time since diagnosis of 
breast cancer (if 
applicable): 
 
___________________________ 
Time since end of 
treatment for breast 
cancer (if applicable): 
 
___________________________ 
BRCA 1/2  status Positive  
Negative  
Unknown  
Previous other cancer 
(please tick): 
 
Yes  
No  
Family history of breast 
cancer (please tick):  
 
Yes  
No  
Family history of other 
cancer (please tick):  
 
Yes  
No  
Risk-reducing surgery 
(please tick): 
 
Contralateral  
Bilateral  
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Appendix 9: Hospital Anxiety and Depression Scale 
 
 
HADS removed for copyright purposes 
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Appendix 10: Interview Guide (with refinements) 
 
 
 
 
 
 
 
Interview Guide (patients) 
Patient and surgeon decision-making in risk-reducing mastectomy: an ethical 
and empirical analysis 
 
Interviews will be at a time convenient for the patient. The interview will be conducted at 
the hospital, at the patient’s home or by telephone as the participant prefers. For 
consistency, and to ensure that the research questions are addressed, a semi-structured 
approach will be used, with participants prompted to address specific topics in each 
interview.  
 
Closed questions will be avoided as much as possible as these constrain the information 
gained from the participants. For this reason also, interruptions from the interviewer will be 
kept to a minimum with interviewer dialogue limited to reflecting, prompting and 
summarising, with open or closed questions and probing where necessary. To avoid 
generalised responses, participants will be encouraged to speak about their specific 
experiences as much as possible.   
 
Before the interview commences it is essential to ensure that the patient has read the 
information sheet, and that they have made a decision and do not plan to revisit it in the 
next three months. 
Questions and prompts below are resources on which the interviewer will draw and only 
relevant questions should be asked. Questions should not be imposed to disrupt 
conversational style.  
 
1. Introduction  
 
2. Reassurance of confidentiality (including reassurance that their doctors and nurses 
and other clinicians will not be told what the participant has said and that their treatment 
will not be affected by what they say, unless they say something that indicates risk) 
 
3. Clarification of research aims 
 
4. Elicit and answer questions about the interview process and the Patient Information 
Sheet 
 
5.0 The interview questions will be guided by the structure below. The questions are 
illustrative and the format and sequencing will be guided by the patient’s responses. 
Trust Information Removed 
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5.1 Background 
At what point did you first consider RRM? 
How did you come to consider RRM? 
(if patient spontaneously considered RRM) Where did you hear of RRM? 
5.2 Decision-making 
Could you please describe how you made the decision to have/not have RRM? 
How did you feel during decision-making?  
What sort of issues did you consider when you were deciding whether you wanted 
RRM? 
Of these, which issues were important to you? 
What sort of information did you seek, to help you make that decision? 
To what extent did you consider the risk of cancer?  
(if so) How high or low did the risk of cancer seem to you? 
What factors did you think contribute to risk?       
How did you feel about this risk? 
Did you approach anyone to help you to make the decision? Who? 
What was the most important contributor to your decision-making? 
Elicit information about timeline- e.g. what can first / second? 
5.3 Decision process 
Which clinical staff did you talk to about your decision? 
How did each staff member respond to you? 
Who raised the prospect of you having an RRM? 
 (lower risk CRRM only) Can you tell me when and how you indicated to your surgeon 
that you were interested in CRRM? 
(lower risk CRRM only) How did your surgeon respond when you indicated that you 
were interested in CRRM?  
     What did you want to get out of the discussions with your 
family/doctor/nurse/counsellor? 
     Did [family/doctor/nurse/counsellor] speak to you about the risks associated with your 
decision? 
    Who spoke to you first about the risks associated with your decision? 
Use similar questions 
to ask about other 
issues mentioned 
(e.g., risk of operation, 
cosmetics etc.) 
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Could you describe how talking to clinical staff or family influenced your decision? 
How did the role of worry/emotions/risk shape up your decision? 
5.4. Decision satisfaction 
 
How do you feel about your decision now? 
 
    When was it clear to you that you wanted this?  
    What were your thoughts at that time? 
What would you (give up) to reduce risk?  
 
6. Does the participant have any questions or any concerns about anything that has 
been talked about? 
 
Rating risk pre surgery (%) / post surgery (%).  
 
7. Thank participant for taking part. 
 
NOTE: If a patient brings up the following, try to ask for more information on these areas: 
“need to get on with life” – how is this stopping you from getting on with your life? 
“need to be in control” – what does being in control mean to you? 
“want to avoid chemotherapy/mammograms” – how has this influenced your decision for 
wanting risk-reducing mastectomy? 
 
 
Italics: Refinements 
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Appendix 11: Dealing with distress protocol 
Dealing with distress 
 
Within the information sheet, participants are informed that they do not have to take 
part in the study and are free to withdraw at any point without negative 
consequences for the participant. The researcher will reiterate this information as 
regularly as is felt necessary.   
If a participant becomes distressed during the course of the interview (visually 
appears distressed or informs the researcher that this is the case), the interview will 
be paused and the participant will be asked if she wishes to continue, or if she 
wishes to interrupt or stop the interview and/or if she wishes to discuss her concerns 
with the researcher. 
If the researcher is concerned about the degree of distress, the participant should be 
encouraged to contact their GP or mental health provider or’ with the participant’s 
consent, the researcher will ask a member of the research team to do so. With 
consent, the researcher will inform the Clinical Psychologist from the Breast Cancer 
Unit (name) of the distress experienced.  
If the researcher is concerned that the participant is at risk of harm, or that someone 
else is at risk, she will seek her consent to refer these concerns to an appropriate 
clinician. However, the duty of care would mean that, even if consent were not 
provided, the researcher would need to make this referral as appropriate.  
If the participant feels able and the researcher agrees, the interview will be resumed. 
With her consent, the participant will be contacted the following day. The participant 
will be encouraged to contact the research team if she experiences increased 
distress in the hours/ days following the interview. Contact numbers for the research 
team are supplied on the participant information sheet.  
If a participant becomes distressed the researcher will record the action taken.  
If the participant feels unhappy with the interview process and wishes to complain, 
the participant will be directed to the contact details for the Customer Relations 
Team on the participant information sheet.  
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Appendix 12: Data Protection Protocol 
 
Data Protection 
 
Demographic information will be pseudo-anonymised (to link with interview 
transcript) and all potentially identifying information will be removed/ replaced with a 
code. Information will be stored electronically at Liverpool University on a secure 
password protected computer system. Research team members only will have 
access to the transcripts during analysis. Following transfer to the computer, raw 
data (paper files e.g. demographic information) will be stored in the D.Clin.Psychol. 
office. 
Interviews will be recorded on a digital Dictaphone; audio data will be transferred on 
to a university password protected computer as soon as possible. Following transfer 
to computer, audio data stored on the Dictaphone will be deleted.  
A university recognised transcription service will be responsible for all transcriptions. 
[Researcher] will be responsible for ensuring that the transcription service employed 
during the investigation has deleted all electronic copies of the data from their 
computer hard drives/portable disk drives etc. sent by [Researcher]. When data is 
part of the wider study and sent for transcription by a member of the wider research 
team, responsibility for data deletion will fall to the data custodian, [Chief 
Investigator/ supervisor]. 
Transcriptions will be pseudo-anonymised with respect to all names of people and 
places and other potentially identifying information. Transcripts will be stored 
electronically at Liverpool University on a secure password protected computer 
system. Research team members only will have access to the transcripts during 
analysis. 
(Trainee) will retain an electronic copy of all transcribed files for her own records until 
the point of the viva voca examination. Up-to-date copies of all electronic files 
(relevant to the thesis) will be stored on [Researcher] allocated workspace on the 
University computer network. Transcribed files will not be kept on any home PC. 
 
Following the viva voca examination, [Trainee] will submit hard data to the 
D.Clin.Psychol. office for secure destruction by the University Records Management 
Service.  
All the electronic data relating to the thesis will be archived to CD. The CD containing 
the electronic data and any remaining copies of the raw hard data, such as 
participant consent forms, will be given to the data custodian [Chief Investigator / 
supervisor] who will be responsible for data storage. Transcripts will be archived with 
the Economic and Social Data Service for access by other researchers (data sharing 
procedures are explained in ESDS (2012) Managing and Sharing Data (p. 23) 
http://www.data-archive.ac.uk/media/2894/managingsharing.pdf). This will be 
explained to patients and they will be asked to consent to it. 
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It is the responsibility of the data custodian to ensure that all hard and electronic 
copies of any data files that relate to the major research project at the end of the 
data retention period have been securely destroyed.    
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Appendix 13: Data analysis Example Vignette 
ID1: This patient was a young mum and had had breast cancer before. She was 
driven by the anxiety of the cancer returning, reducing her life expectancy and her 
not being around for her young children. She wanted to have the CRRM and not go 
through the yearly mammograms and chemotherapy again, which were both horrible 
experiences. She had an attachment with the surgeon as she has performed the 
previous surgery wanted to do whatever she could to reduce the risk of getting 
cancer again. 
 
Appendix 14: Example of summary of analysis meeting 
15/04/14 
Implications for the interviews – what do women mean by ‘doing everything I can’ 
- What don’t the women do? – at what point do the women think ‘I’ve done all I 
can’? 
- What else do women do to reduce the risk? 
- What else do women feel about the fear –can they quantify the fear? 
Intensity/constancy (never leaves them)? 
- Mammograms = lack of trust / bad experience / does not want to wait for it to 
come back 
- Heterogeneity of fear – fear of lurking ‘thing’ / variation of what they are fearful of 
/ individualised fear / universal fear 
- Nature of fear – uniformity of an imposter in one’s own body 
- Intrinsic fear – social fear – in what to do – availability of information of options 
- Only way you know what is reasonable and what can be done is from knowledge 
that is socially transmitted 
- Fear of regret – Is the anticipated regret driving the decision or is it about doing 
everything they can? 
- Logic of decision-making may be either rational or ‘get it out of here’ response – 
why the difference matters? 
- Bad experience –metaphor of cancer 
- Vicarious experience 
Intense menace 
Menacing – rather than inevitability – fits with the fear – something lurking that merits 
extremes measures 
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- Capacity that the monster that lurks cannot be stopped unless drastic measures 
are taken – removed from the territory 
Risk-reducing 
RR is important – only care about where it ends as long as its reducing – not  by 
degree – downwards trajectory – done whatever I can do to reduce the risk – not 
talking about combinations for reducing the risk 
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Appendix 15 Example of Initial Analysis (for fear/ vulnerability) 
February 2014 
 
Emerging themes 
 
Possible Subthemes Interview ID and line 
number 
Example Quotes 
Fear/worry/anxiety ? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Vulnerability ID1: 232, 250, 438-439, 444-445, 447, 
640, 652-654, 947 
 
ID3: 108-124 
 
 
 
“…I suppose I want to live with a little less fear than I live now.” (ID1) 
 
“Because mine [test results] were triple negative I, it was, the tablets were no use to me 
because…now I know it’s genetic…but I couldn’t understand last year. I thought, why are 
they all on pills for hormones and mine was triple negative? What caused it? Something 
must have caused it…so I thought I’m feeling vulnerable that if it happened again all I’ve got 
to rely on is chemotherapy…which I didn’t enjoy going through…I had no protection, so I 
didn’t know up to then what had caused it until my genetic test.” ID3 
 
Perception of existence as 
dangerous  
ID1: 524, 537-538 
 
ID1: 289-293 
“I know my life expectancy is going to be less that the other guys who’ve not had it.” (ID1) 
think, I suppose not would help because you know they can’t… nobody’s going to say to you, 
you’re free of it.  That’s it, it’s gone… gone.  You know, your body can turn bandit at any 
point, can’t it? (ID1) 
 
Anticipating fear of cancer 
returning again that was 
driving her decision 
ID1: 190-191, 318, 484-485, 745-747, 
788-793, 947-948 
 
 
 
“Once you have come to that decision feelings around, um, I don’t want this to happen, I 
don’t want this to happen again and actually that was almost more important than 
perhaps…I don’t want it to happen again and I don’t want to have…I don’t want to find a 
lump. I don’t want to have a mammogram again.” (ID1) 
 
Fear about future motivates 
her decisions and her 
emotions in the future  
ID1: 302-304, 507-509, 561, 799-800 “…well, there’s no alternative. You either have surgery or you don’t, or you just change your 
life, you change everything to give yourself the best chance.” (ID1) 
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ID2: 269-273, 477-478, 766, 771, 787, 815 
 
 
 
 
 
 
 
ID3: 412-422 
 
ID4: 150 
 
 
“I’m in my late thirties now, my sister and my cousin were diagnosed sort of mid-forties, you 
know, 46, 45 er early forties you know. Five years from now will take me up to my sister and 
my cousin’s age so, you know…and that’s how…I’m a very logical person, I kind of see things 
in, in stages like that.” (ID2) 
 
“Once I have the operation done I’ll be so relieved and I’m looking forward to just getting 
back to normality again. Don’t want to go down that road again of going what I went 
through last year…the chemotherapy was the worst…I didn’t like that. It’s all the side-effects 
and everything. It took me a year to get over all the effects from that.” (ID3) 
 
“…I want a baby as well…that’s an emotional thing I suppose…I want a baby, and everyone’s 
getting pregnant and not me” (ID4) 
 
“I feel I got cancer due to having the baby as well…because it was hormonal and it was 
ductal…I had milk for nearly three years. I shouldn’t have had milk, so I think that’s why I 
developed breast cancer, so if I get rid of the other one and have another baby, then it will be 
okay.” 
 
Emotions for the 
consequences of her 
decision to have surgery 
ID2: 370-377, 412-414, 441 “But then I found myself. ..stopping and then saying to my husband, oh well actually, that, 
that’s me. It’s affecting me.” (ID2) 
 
Managing the worry rather 
than making the decision 
ID1: 454-455 “I suppose at this point it’s psychological, isn’t it, that I don’t want to ever find a lump…in my 
breast again” (ID1) 
 
“The fear is always going to be psychological. I think it’s more of a psychological decision 
that you make.” (ID1) 
 
“The fear of, of, of that rather than perhaps weighing up the risk” (ID1) 
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Worry of entering the 
“Danger zone” 
ID2: 269-273 
 
 
 
 
ID3: 261-267 
 
 
“I’m in my late thirties now, my sister and cousin were diagnosed sort of mid-forties…Five 
years from now will take me up to my sister and my cousin’s age…I’m a very logical person, I 
kind of see things, in stages like that.” (ID2) 
 
“I made that decision the end of last year to the doctors in the hospital, please take them out, 
I don’t want them…I don’t want that worry, what I seen what my mum went through. So 
yeah, I had open surgery in the end of January this year…I had them removed, and my tubes, 
so, so relieved.” 
 
 “I feel I got cancer due to having the baby as well…because it was hormonal and it was 
ductal…I had milk for nearly three years. I shouldn’t have had milk, so I think that’s why I 
developed breast cancer, so if I get rid of the other one and have another baby, then it will be 
okay.” (ID4) 
Avoiding mammogram and 
three week test results 
ID1: 76-78, 792 
 
ID3: after interview the patient added this 
point that she felt was import ant 
 
“…you have to wait three weeks for that, and I was just sat there thinking, I just don’t want 
to do that.” (ID1) 
 
An important reason for the decision to have RRM was to avoid having mammograms again 
in the future. It wasn’t the fact of how uncomfortable they were but more the worry over the 
3 weeks whilst waiting for the results. She did not want that every year for the rest of her life 
and having the surgery meant she would not need to go for the mammograms anymore 
which were a big factor in her decision to have the RRM. (ID3). 
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Appendix 16: Example data analysis- conceptual categories (Fear)3 
1: I want to life a live with a little less fear: Fear is important in DM 
 Women’s decisions seem to be driven by fear of cancer returning (?). 
 Fear of having to go through treatment again particularly chemotherapy and 
fear /anxiety following mammograms (hard to know if this is their justification 
for the decision they have made).  
 Fear of dying and leaving their family, particularly young children.  
 Women explicitly stating that the decision is driven by fear.  
 Fear and worry as ‘constant’  
 Timeline- initial emotional reaction/ logical process after – where does 
decision get made?  
 Where is fear from? Fear for life? Innate versus socially-mediated fear 
response 
 Cancer as avoiding detection/ lurking and insidious 
 Cancer as a hidden ‘menace’ 
 Social processes impacting upon fear? E.g. the ‘big C’ (less support for this 
now). 
Request to ‘get it off’ interpreted as request for RRM  
 Experience of having breast cancer colours/ impacts upon fear.  
 May be heterogeneity in fear – possible that not everyone if frightened of 
same thing? 
 
 
 
 
 
 
 
                                                        
3 For full details see data CD 
